Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 983 articles:
HTML format

Single Articles

    January 2024
  1. CZARNEK G, Kossowska M
    Strong correlational but no causal evidence on the link between the perception of scientific consensus and support for vaccination.
    PLoS One. 2024;19:e0296066.
    PubMed     Abstract available

  2. FLUSBERG SJ, Mackey A, Semino E
    Seatbelts and raincoats, or banks and castles: Investigating the impact of vaccine metaphors.
    PLoS One. 2024;19:e0294739.
    PubMed     Abstract available

  3. MATSUMURA A, Garg R, Hussain M, Matsumura ME, et al
    Political orientation of online media sources and reporting of Covid-19 vaccine myocarditis.
    PLoS One. 2024;19:e0296295.
    PubMed     Abstract available

  4. ALALAWI M, Alsalloum MA, Garwan YM, Abuzeid M, et al
    COVID-19 vaccine hesitancy among healthcare workers in Arab Countries: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296432.
    PubMed     Abstract available

  5. RABIENIA M, Mortazavidehkordi N, Roudbari Z, Daneshi R, et al
    Designing of a new multi-epitope vaccine against Leishmania major using Leish-F1 epitopes: An In-silico study.
    PLoS One. 2024;19:e0295495.
    PubMed     Abstract available

  6. SAFARI D, Daningrat WOD, Milucky JL, Khoeri MM, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae among children <5 years of age in Indonesia prior to pneumococcal conjugate vaccine introduction.
    PLoS One. 2024;19:e0297041.
    PubMed     Abstract available

  7. Expression of Concern: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    PLoS One. 2024;19:e0297253.

    Trumpism, climate and COVID: Social bases of the new science rejection.
    PLoS One. 2024;19:e0293059.
    PubMed     Abstract available

  9. ETERAFI M, Fouladi N, Golizadeh M, Shaker H, et al
    Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study.
    PLoS One. 2024;19:e0296669.
    PubMed     Abstract available

  10. AL-KAIF LAIK, Al-Ameri H, Alfatlawi WRO, Mahdi AE, et al
    Detection of CTLA-4 level and humeral immune response after the second dose of COVID-19 vaccine in certain Iraqi provinces participants.
    PLoS One. 2024;19:e0296521.
    PubMed     Abstract available

  11. SETIAWAN D, Nurulita NA, Khoirunnisa SM, Postma MJ, et al
    The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women.
    PLoS One. 2024;19:e0290808.
    PubMed     Abstract available

  12. AIMAN S, Farooq QUA, Han Z, Aslam M, et al
    Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile.
    PLoS One. 2024;19:e0293731.
    PubMed     Abstract available

  13. SAAKA SA, Mohammed K, K A Pienaah C, Luginaah I, et al
    Child malaria vaccine uptake in Ghana: Factors influencing parents' willingness to allow vaccination of their children under five (5) years.
    PLoS One. 2024;19:e0296934.
    PubMed     Abstract available

  14. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed     Abstract available

  15. HOBBS A, Aldosery A, Kostkova P
    Low credibility URL sharing on Twitter during reporting linking rare blood clots with the Oxford/AstraZeneca COVID-19 vaccine.
    PLoS One. 2024;19:e0296444.
    PubMed     Abstract available

  16. VENKATESAN MM, Barnoy S, Frenck R, McNeal M, et al
    B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3.
    PLoS One. 2024;19:e0290987.
    PubMed     Abstract available

  17. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    PubMed     Abstract available

  18. SOW A, Diallo C, Cherifi H
    Interplay between vaccines and treatment for dengue control: An epidemic model.
    PLoS One. 2024;19:e0295025.
    PubMed     Abstract available

  19. TREGNAGO D, Avancini A, Belluomini L, Trestini I, et al
    Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
    PLoS One. 2024;19:e0290792.
    PubMed     Abstract available

  20. LIU CC, Ling J, Zahry NR, Liu C, et al
    Using the Theory of Planned Behavior to determine COVID-19 vaccination intentions and behavior among international and domestic college students in the United States.
    PLoS One. 2024;19:e0293130.
    PubMed     Abstract available

  21. GEHRING S, Kowalzik F, Okasha O, Engelmann T, et al
    A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.
    PLoS One. 2024;19:e0294025.
    PubMed     Abstract available

  22. ASADI-POOYA AA, Nemati M, Shahisavandi M, Nemati H, et al
    How does COVID-19 vaccination affect long-COVID symptoms?
    PLoS One. 2024;19:e0296680.
    PubMed     Abstract available

  23. AGIMAS MC, Asmamaw M, Mekonen N, Mamo F, et al
    Spatial pattern and associated factors of timely vaccination in Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
    PLoS One. 2024;19:e0296123.
    PubMed     Abstract available

  24. LAUE T, Junge N, Leiskau C, Mutschler F, et al
    Diminished measles immunity after paediatric liver transplantation-A retrospective, single-centre, cross-sectional analysis.
    PLoS One. 2024;19:e0296653.
    PubMed     Abstract available

  25. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    PubMed     Abstract available

  26. UDOAKANG AJ, Nganyewo NN, Djomkam Zune AL, Olwal CO, et al
    Knowledge, attitude and perception towards COVID-19 among representative educated sub-Saharan Africans: A cross-sectional study during the exponential phase of the pandemic.
    PLoS One. 2024;19:e0281342.
    PubMed     Abstract available

  27. TAKEBAYASHI M, Namba M, Kaneda Y, Koyama T, et al
    How can we promote vaccination of the mass population?-Lessons from the COVID-19 vaccination defaults.
    PLoS One. 2024;19:e0298983.
    PubMed     Abstract available

  28. PELLETIER C, Gagnon D, Dube E
    "It's not that I don't trust vaccines, I just don't think I need them": Perspectives on COVID-19 vaccination.
    PLoS One. 2024;19:e0293643.
    PubMed     Abstract available

  29. MANZEMU DG, Opara JPA, Kasai ET, Mumbere M, et al
    Rotavirus and adenovirus infections in children with acute gastroenteritis after introducing the Rotasiil(R) vaccine in Kisangani, Democratic Republic of the Congo.
    PLoS One. 2024;19:e0297219.
    PubMed     Abstract available

  30. VEPACHEDU S, Nurzenska A, Lohiniva AL, Hudi AH, et al
    Understanding COVID-19 vaccination behaviors and intentions in Ghana: A Behavioral Insights (BI) study.
    PLoS One. 2024;19:e0292532.
    PubMed     Abstract available

  31. BALEGHA AN, Abdul-Aziz S, Mornah L
    Healthcare professionals' perception and COVID-19 vaccination attitudes in North-Western Ghana: A multi-center analysis.
    PLoS One. 2024;19:e0298810.
    PubMed     Abstract available

  32. GILANO G, Sako S, Molla B, Dekker A, et al
    The effect of mHealth on childhood vaccination in Africa: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0294442.
    PubMed     Abstract available

  33. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    PubMed     Abstract available

  34. BEN-UMEH KC, Kim J
    Income disparities in COVID-19 vaccine and booster uptake in the United States: An analysis of cross-sectional data from the Medical Expenditure Panel Survey.
    PLoS One. 2024;19:e0298825.
    PubMed     Abstract available

  35. ADINKRAH EK, Bazargan S, Cobb S, Kibe LW, et al
    Mobilizing faith-based COVID-19 health ambassadors to address COVID-19 health disparities among African American older adults in under-resourced communities: A hybrid, community-based participatory intervention.
    PLoS One. 2024;19:e0285963.
    PubMed     Abstract available

  36. ABER JO, Bongomin F, Opio SL, Ochola E, et al
    Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study.
    PLoS One. 2024;19:e0297617.
    PubMed     Abstract available

  37. HOU Y, Bidkhori H
    Multi-feature SEIR model for epidemic analysis and vaccine prioritization.
    PLoS One. 2024;19:e0298932.
    PubMed     Abstract available

  38. Retraction: Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus.
    PLoS One. 2024;19:e0300096.

  39. KONLAN MY, Mahama F, Abubakari BB, Konka P, et al
    Predictors of vaccination card retention in Tamale Metropolis, Ghana.
    PLoS One. 2024;19:e0292765.
    PubMed     Abstract available

  40. DIAS E, Diniz AMA, Souto GR, Guerra HL, et al
    Predicting COVID-19 cases in Belo Horizonte-Brazil taking into account mobility and vaccination issues.
    PLoS One. 2024;19:e0269515.
    PubMed     Abstract available

  41. BASHIR IM, Al-Waleedi AA, Al-Shaibani SM, Rajamanar M, et al
    Strengthening laboratories in response to outbreaks in humanitarian emergencies and conflict settings: Results, challenges and lessons from expanding PCR diagnostic capacities for COVID-19 testing in Yemen.
    PLoS One. 2024;19:e0298603.
    PubMed     Abstract available

  42. WU S, Li Y, Baral S, Mishra S, et al
    Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada.
    PLoS One. 2024;19:e0299304.
    PubMed     Abstract available

  43. SENJAM SS, Manna S, Goel G, Balhara YPS, et al
    Vaccination coverage against COVID-19 among rural population in Haryana, India: A cross-sectional study.
    PLoS One. 2024;19:e0299564.
    PubMed     Abstract available

  44. TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
    Understanding uptake of COVID-19 testing, vaccination, and boosters among Spanish-speaking Latines in the United States: Qualitative insights from Spanish speakers and key informants.
    PLoS One. 2024;19:e0296812.
    PubMed     Abstract available

  45. GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
    Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.
    PLoS One. 2024;19:e0300198.
    PubMed     Abstract available

  46. ZHANG X, Han X, Chen B, Fu X, et al
    Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
    PLoS One. 2024;19:e0289255.
    PubMed     Abstract available

  47. AGIMAS MC, Alemayehu MA, Derseh NM, Aragaw FM, et al
    Correction: Spatial pattern and associated factors of timely vaccination in Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
    PLoS One. 2024;19:e0300482.
    PubMed     Abstract available

  48. MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
    COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
    PLoS One. 2024;19:e0299568.
    PubMed     Abstract available

  49. WILLIAMS SV, Akande T, Abbas K
    Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.
    PLoS One. 2024;19:e0297326.
    PubMed     Abstract available

  50. KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
    Minimal change disease following COVID-19 vaccination: A systematic review.
    PLoS One. 2024;19:e0297568.
    PubMed     Abstract available

  51. SCHRIJVERS-GONLAG M, Skarpe C, Julkunen-Tiitto R, Poleo ABS, et al
    Phenolic concentrations and carbon/nitrogen ratio in annual shoots of bilberry (Vaccinium myrtillus) after simulated herbivory.
    PLoS One. 2024;19:e0298229.
    PubMed     Abstract available

  52. ARUMAE K, Realo A, Ausmees L, Allik J, et al
    Self- and informant-reported personality traits and vaccination against COVID-19.
    PLoS One. 2024;19:e0287413.
    PubMed     Abstract available

  53. SUWANBAMRUNG C, Srinam B, Promkool P, Suwannakarn W, et al
    Uptake of COVID-19 vaccine among high-risk urban populations in Southern Thailand using the COM-B model.
    PLoS One. 2024;19:e0300509.
    PubMed     Abstract available

  54. PANG Y, Robbs C, Wang J
    A longitudinal study of the COVID-19 pandemic impact on mental health in ophthalmic personnel and students.
    PLoS One. 2024;19:e0300144.
    PubMed     Abstract available

  55. TOWNSLEY H, Gahir J, Russell TW, Greenwood D, et al
    COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
    PLoS One. 2024;19:e0294897.
    PubMed     Abstract available

  56. LEE DH, Lee SH, Kim AR, Quan FS, et al
    Correction: Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.
    PLoS One. 2024;19:e0301214.
    PubMed     Abstract available

  57. LI Y, Li J, He J, Tao C, et al
    AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
    PLoS One. 2024;19:e0300919.
    PubMed     Abstract available

  58. LANZA-LEON P, Cantarero-Prieto D, Pascual-Saez M
    Exploring trends and determinants of basic childhood vaccination coverage: Empirical evidence over 41 years.
    PLoS One. 2024;19:e0300404.
    PubMed     Abstract available

  59. GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
    Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination.
    PLoS One. 2024;19:e0298272.
    PubMed     Abstract available

  60. ZHENG D, Sun Q, Su Z, Kong F, et al
    Correction: Enhancing Specific-Antibody Production to the ragB Vaccine with GITRL That Expand Tfh, IFN-gamma+ T Cells and Attenuates Porphyromonas gingivalis Infection in Mice.
    PLoS One. 2024;19:e0301151.
    PubMed     Abstract available

  61. KOSKAN A, Larkey L, Todd M, Kim SW, et al
    Protocol for a community-based digital storytelling pilot intervention to reduce Hispanic parents' vaccine hesitancy to immunize their children against COVID-19.
    PLoS One. 2024;19:e0299787.
    PubMed     Abstract available

  62. TRZEBINSKI W, Trzebinski J
    How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
    PLoS One. 2024;19:e0300814.
    PubMed     Abstract available

  63. UMER BA, Noyce RS, Kieser Q, Favis NA, et al
    Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models.
    PLoS One. 2024;19:e0298437.
    PubMed     Abstract available

  64. STOSIC M, Plavsa D, Jovanovic V, Veljkovic M, et al
    Factors associated with COVID-19 among hospitalized patients with severe acute respiratory infections in Serbia, 2022-2023: A test negative case-control study.
    PLoS One. 2024;19:e0299210.
    PubMed     Abstract available

  65. WALSH-BUHI ML, Houghton RF, Valdez D, Walsh-Buhi ER, et al
    A theory-based assessment of mpox: Findings from a nationally representative survey of U.S. adults.
    PLoS One. 2024;19:e0299599.
    PubMed     Abstract available

  66. LEE KS, Go MJ, Choi YY, Kim MK, et al
    Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service.
    PLoS One. 2024;19:e0300306.
    PubMed     Abstract available

  67. AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
    Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
    PLoS One. 2024;19:e0301198.
    PubMed     Abstract available

  68. BRAY LA, Jervis LL, Janitz AE, Ross L, et al
    Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.
    PLoS One. 2024;19:e0300872.
    PubMed     Abstract available

  69. DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
    Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
    PLoS One. 2024;19:e0301056.
    PubMed     Abstract available

  70. PAUDEL S, Apostolakos I, Vougat Ngom R, Tilli G, et al
    A systematic review and meta-analysis on the efficacy of vaccination against colibacillosis in broiler production.
    PLoS One. 2024;19:e0301029.
    PubMed     Abstract available

  71. THERESA POOL SN, Shroff EH, Chetty A, Lewis L, et al
    Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.
    PLoS One. 2024;19:e0299747.
    PubMed     Abstract available

  72. AGIMAS MC, Belew AK, Sisay M, Daniel Baffa L, et al
    Spatial variations and determinants of timely completion of vaccination in Ethiopia using further analysis of EDHS 2019 data: Spatial and multilevel analysis.
    PLoS One. 2024;19:e0301409.
    PubMed     Abstract available

  73. FISMAN DN, Amoako A, Simmons A, Tuite AR, et al
    Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority.
    PLoS One. 2024;19:e0297093.
    PubMed     Abstract available

  74. SILVA LA, Souza MF, Carvalho TP, Santana CH, et al
    Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.
    PLoS One. 2024;19:e0298117.
    PubMed     Abstract available

  75. HERNANDEZ-BELLO J, Lorenzo-Leal AC, Munoz-Valle JF, Morales-Nunez JJ, et al
    Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.
    PLoS One. 2024;19:e0299520.
    PubMed     Abstract available

  76. MWANGI LW, Omuse G, Adam R, Ong'ete G, et al
    Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and non-clinical healthcare workers at a tertiary facility in Kenya.
    PLoS One. 2024;19:e0299302.
    PubMed     Abstract available

  77. ECHEVERRI TRIBIN F, Williams E, Testamarck V, Carreno JM, et al
    Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort.
    PLoS One. 2024;19:e0292566.
    PubMed     Abstract available

  78. RICCI CONESA H, Skroder H, Norton N, Bencina G, et al
    Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.
    PLoS One. 2024;19:e0297098.
    PubMed     Abstract available

  79. THANGARAJ JWV, Prosperi C, Kumar MS, Hasan AZ, et al
    Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    PLoS One. 2024;19:e0297385.
    PubMed     Abstract available

  80. ALAMARES-SAPUAY J, Kishko M, Lai C, Parrington M, et al
    Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate DeltaNS2/Delta1313/I1314L increase the stability of infectivity and content of prefusion F protein.
    PLoS One. 2024;19:e0301773.
    PubMed     Abstract available

  81. UNFRIED K, Priebe J
    Who shares fake news on social media? Evidence from vaccines and infertility claims in sub-Saharan Africa.
    PLoS One. 2024;19:e0301818.
    PubMed     Abstract available

  82. RAZAI MS, Mansour R, Ravindran P, Freeman S, et al
    Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review.
    PLoS One. 2024;19:e0298407.
    PubMed     Abstract available

  83. HOSSAIN FB, Jayasinghe S, Blazek K, He WQ, et al
    Pneumococcal vaccination and primary care presentations for acute respiratory tract infection and antibiotic prescribing in older adults.
    PLoS One. 2024;19:e0299924.
    PubMed     Abstract available

  84. ZHANG Q, Tiwari S, Wen J, Wang S, et al
    Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.
    PLoS One. 2024;19:e0300524.
    PubMed     Abstract available

  85. RENEER ZB, Bergeron HC, Reynolds S, Thornhill-Wadolowski E, et al
    mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge.
    PLoS One. 2024;19:e0297833.
    PubMed     Abstract available

  86. BADE V, Schmitz H, Tawiah BB
    Regional variations in vaccination against COVID-19 in Germany.
    PLoS One. 2024;19:e0296976.
    PubMed     Abstract available

  87. SANVEE-BLEBO LM, Adewuyi PA, Whesseh FK, Babalola OJ, et al
    COVID-19 vaccine hesitancy among adults in Liberia, April-May 2021.
    PLoS One. 2024;19:e0297089.
    PubMed     Abstract available

  88. ZAID SNA, Abdul Kadir A, Mohd Noor N, Ahmad B, et al
    Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia.
    PLoS One. 2024;19:e0302237.
    PubMed     Abstract available

  89. LERDSAMRAN H, Anusorntanawat R, Sangsiriwut K, Sawadpongpan S, et al
    Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients.
    PLoS One. 2024;19:e0298033.
    PubMed     Abstract available

  90. TAN H, Liu J, Zhang Y
    Effects of COVID-19 vaccine safety framing on parental reactions.
    PLoS One. 2024;19:e0302233.
    PubMed     Abstract available

  91. MARQUEZ-MARTINEZ S, Salisch N, Serroyen J, Zahn R, et al
    Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
    PLoS One. 2024;19:e0299215.
    PubMed     Abstract available

  92. THIELMANN A, Schmitz MT, Welchowski T, Weltermann B, et al
    Effectiveness of the online-eLearning program KeepCoool at improving the vaccine cold chain in general practices.
    PLoS One. 2024;19:e0301847.
    PubMed     Abstract available

  93. KYAKUWA N, Kimbugwe G, Nakanjako F, Kalute H, et al
    High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
    PLoS One. 2024;19:e0277072.
    PubMed     Abstract available

  94. LIN L, Demirhan H, P Johnstone-Robertson S, Lal R, et al
    Assessing the impact of Australia's mass vaccination campaigns over the Delta and Omicron outbreaks.
    PLoS One. 2024;19:e0299844.
    PubMed     Abstract available

  95. SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
    Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
    PLoS One. 2024;19:e0298771.
    PubMed     Abstract available

  96. O'KENNEDY MM, Roth R, Ebersohn K, du Plessis LH, et al
    Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
    PLoS One. 2024;19:e0301340.
    PubMed     Abstract available

  97. CHISTY ZA, Li DD, Haile M, Houston H, et al
    Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.
    PLoS One. 2024;19:e0301367.
    PubMed     Abstract available

  98. COGILL S, Nallamshetty S, Fullenkamp N, Heberer K, et al
    Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.
    PLoS One. 2024;19:e0290221.
    PubMed     Abstract available

  99. FANG F, Clemens JD, Zhang ZF, Brewer TF, et al
    Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    PLoS One. 2024;19:e0301830.
    PubMed     Abstract available

  100. KHAMI MR, Karimi M, Folayan MO, Shamshiri AR, et al
    Patients' knowledge about dental emergencies, COVID-19 transmission, and required preparations in dental settings.
    PLoS One. 2024;19:e0301460.
    PubMed     Abstract available

  101. KASSA ZY, Scarf V, Turkmani S, Fox D, et al
    Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study.
    PLoS One. 2024;19:e0301994.
    PubMed     Abstract available

  102. RAZAFINDRAKOTO M, Roubaud F, Castilho MR, Pero V, et al
    Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.
    PLoS One. 2024;19:e0288894.
    PubMed     Abstract available

  103. TAMARGO JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, et al
    Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
    PLoS One. 2024;19:e0297327.
    PubMed     Abstract available

  104. YAMAJI T, Harada T, Hashimoto Y, Nakano Y, et al
    Effects of BNT162b2 mRNA Covid-19 vaccine on vascular function.
    PLoS One. 2024;19:e0302512.
    PubMed     Abstract available

  105. HWANG LA, Vaithilingam S, Ng JWJ, Nair M, et al
    The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
    PLoS One. 2024;19:e0301383.
    PubMed     Abstract available

  106. JANNAT Z, Das H, Ali MW, Wahed T, et al
    Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
    PLoS One. 2024;19:e0302056.
    PubMed     Abstract available

  107. JOHN FA, Criollo V, Gaghan C, Armwood A, et al
    Immunization of turkeys with Clostridium septicum alpha toxin-based recombinant subunit proteins can confer protection against experimental Clostridial dermatitis.
    PLoS One. 2024;19:e0302555.
    PubMed     Abstract available

  108. CHENG MC, Lai GH, Tsai YL, Lien YY, et al
    Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene.
    PLoS One. 2024;19:e0303371.
    PubMed     Abstract available

  109. KUMAR A, Misra G, Mohandas S, Yadav PD, et al
    Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus.
    PLoS One. 2024;19:e0300507.
    PubMed     Abstract available

  110. RAMOS A, Martins S, Marinho AS, Norton P, et al
    Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
    PLoS One. 2024;19:e0303244.
    PubMed     Abstract available

  111. CHOI Y, Kim IK, Kim SJ, Kim HS, et al
    Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
    PLoS One. 2024;19:e0303050.
    PubMed     Abstract available

  112. RAJOROMANANA B, Nyirenda G, Edosoa GT, Andrianasolo RL, et al
    Dog ecology and rabies control including canine vaccination coverage: Impacts from a survey in Madagascar.
    PLoS One. 2024;19:e0302690.
    PubMed     Abstract available

  113. BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
    PLoS One. 2024;19:e0300731.
    PubMed     Abstract available

  114. NOUR D, Ismail MB, Osman M, Rafei R, et al
    Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
    PLoS One. 2024;19:e0302579.
    PubMed     Abstract available

  115. AGGARWAL S, Singh L, Alam U, Sharma S, et al
    COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    PLoS One. 2024;19:e0294480.
    PubMed     Abstract available

  116. OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
    COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
    PLoS One. 2024;19:e0303172.
    PubMed     Abstract available

  117. VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
    How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
    PLoS One. 2024;19:e0303043.
    PubMed     Abstract available

  118. IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
    BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    PLoS One. 2024;19:e0302722.
    PubMed     Abstract available

  119. Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
    PLoS One. 2024;19:e0303549.

  120. WHELAN AO, Flick-Smith HC, Walker NJ, Abraham A, et al
    A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
    PLoS One. 2024;19:e0294998.
    PubMed     Abstract available

  121. KIM S, Lilani A, Redemptus C, Campana K, et al
    A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    PLoS One. 2024;19:e0300206.
    PubMed     Abstract available

  122. MOIN AT, Rani NA, Patil RB, Robin TB, et al
    In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses.
    PLoS One. 2024;19:e0300778.
    PubMed     Abstract available

  123. URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
    Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
    PLoS One. 2024;19:e0303854.
    PubMed     Abstract available

  124. KHEZRI M, McKnight C, Weng CA, Kimball S, et al
    COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
    PLoS One. 2024;19:e0303394.
    PubMed     Abstract available

  125. WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
    Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2024;19:e0302531.
    PubMed     Abstract available

  126. YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
    Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
    PLoS One. 2024;19:e0303420.
    PubMed     Abstract available

  127. GICHUKI J, Ngoye B, Wafula F
    "I'll take them another day": A qualitative study exploring the socio-behavioral complexities of childhood vaccination in urban poor settlements.
    PLoS One. 2024;19:e0303215.
    PubMed     Abstract available

  128. HURST JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, et al
    Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019).
    PLoS One. 2024;19:e0302400.
    PubMed     Abstract available

  129. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
    Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    PLoS One. 2024;19:e0301997.
    PubMed     Abstract available

  130. COBB J, Rawson J, Gonzalez N, Orr C, et al
    Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
    PLoS One. 2024;19:e0303863.
    PubMed     Abstract available

  131. KASZTELEWICZ B, Skrok K, Burzynska J, Migdal M, et al
    Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.
    PLoS One. 2024;19:e0301612.
    PubMed     Abstract available

  132. TRZEBINSKI W, Trzebinski J
    Correction: How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
    PLoS One. 2024;19:e0304372.
    PubMed     Abstract available

  133. LOPEZ-CODONY V, de Andres-Pablo A, Ferrando-Diez A, Fernandez-Montoli ME, et al
    Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
    PLoS One. 2024;19:e0304080.
    PubMed     Abstract available

  134. YOSHIMURA M, Honda Y, Yonemitsu E, Kuraoka K, et al
    Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    PLoS One. 2024;19:e0301688.
    PubMed     Abstract available

  135. LIU Y, Zhang C, Wang Y, Luo X, et al
    Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
    PLoS One. 2024;19:e0303508.
    PubMed     Abstract available

  136. BRIZUELA M, Palermo MC, Alconada T, Sandoval MM, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0297767.
    PubMed     Abstract available

  137. TAMIR TT, Workneh BS, Mekonen EG, Zegeye AF, et al
    Coverage, spatial distribution and determinants of childhood inactivated poliovirus vaccine immunization in Ethiopia.
    PLoS One. 2024;19:e0301933.
    PubMed     Abstract available

  138. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
    Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
    PLoS One. 2024;19:e0300152.
    PubMed     Abstract available

  139. ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
    Can COVID-19 herd immunity be achieved at a city level?
    PLoS One. 2024;19:e0299574.
    PubMed     Abstract available

  140. MERAYA AM, Syed MH, Shabi AA, Madkhali HA, et al
    Assessment of community pharmacists' knowledge, attitudes and their willingness to provide vaccination services in Saudi Arabia.
    PLoS One. 2024;19:e0304287.
    PubMed     Abstract available

  141. LE T, Flores M, Omaleki V, Hassani A, et al
    Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
    PLoS One. 2024;19:e0295618.
    PubMed     Abstract available

  142. GARG N, Tellier G, Vale N, Kluge J, et al
    Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
    PLoS One. 2024;19:e0303450.
    PubMed     Abstract available

  143. ARTEMCHUK O, Evlampidou I
    Knowledge, attitudes and practices survey towards pneumococcal infection and vaccination among primary health care physicians, Ukraine, 2021.
    PLoS One. 2024;19:e0304346.
    PubMed     Abstract available

  144. SASSE K, Mahabir R, Gkountouna O, Crooks A, et al
    Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
    PLoS One. 2024;19:e0301488.
    PubMed     Abstract available

  145. RIBEIRO LB, Gazzinelli A, Santiago HDC, Fiuza JA, et al
    Public engagement for the conduct of a controlled human infection study testing vaccines against Necator americanus (hookworm) in areas of active hookworm transmission in Brazil.
    PLoS One. 2024;19:e0299022.
    PubMed     Abstract available

  146. CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
    Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
    PLoS One. 2024;19:e0305553.
    PubMed     Abstract available

  147. CHICOINE N, Schnipper N, Griffin J
    The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    PLoS One. 2024;19:e0304416.
    PubMed     Abstract available

  148. BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
    Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
    PLoS One. 2024;19:e0305160.
    PubMed     Abstract available

  149. CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
    Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
    PLoS One. 2024;19:e0305043.
    PubMed     Abstract available

  150. DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
    COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
    PLoS One. 2024;19:e0305314.
    PubMed     Abstract available

  151. ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
    A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
    PLoS One. 2024;19:e0304616.
    PubMed     Abstract available

  152. CHIEN LC, Marquez ER, Smith S, Tu T, et al
    Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
    PLoS One. 2024;19:e0302934.
    PubMed     Abstract available

  153. CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
    Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    PLoS One. 2024;19:e0303303.
    PubMed     Abstract available

  154. GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
    Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
    PLoS One. 2024;19:e0306293.
    PubMed     Abstract available

  155. FARHAN M, Shah Z, Ling Z, Shah K, et al
    Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
    PLoS One. 2024;19:e0304375.
    PubMed     Abstract available

  156. BARDACH A, Ruvinsky S, Palermo MC, Alconada T, et al
    Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304978.
    PubMed     Abstract available

  157. SAMMAN N, Mohabatkar H, Behbahani M, Ganjlikhani Hakemi M, et al
    Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
    PLoS One. 2024;19:e0306117.
    PubMed     Abstract available

  158. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    PubMed     Abstract available

  159. DEBELLUT F, Friedrich A, Baral R, Pecenka C, et al
    The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.
    PLoS One. 2024;19:e0305692.
    PubMed     Abstract available

  160. WERDIN S, Neufeind J
    The implementation of a new measles vaccine mandate in Germany: A qualitative study in local health departments.
    PLoS One. 2024;19:e0306003.
    PubMed     Abstract available

  161. BOTELHO RO, Coelho CCF, Andrade EF, Castelo PM, et al
    Fear of the COVID-19 vaccine in a public healthcare system and university setting.
    PLoS One. 2024;19:e0304000.
    PubMed     Abstract available

  162. CARLOCK MA, Allen JD, Hanley HB, Ross TM, et al
    Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
    PLoS One. 2024;19:e0301157.
    PubMed     Abstract available

  163. AKRONG GB, Hiadzi RA, Donkor AB, Anafo DK, et al
    COVID-19 vaccine acceptance and hesitancy in Ghana: A systematic review.
    PLoS One. 2024;19:e0305993.
    PubMed     Abstract available

  164. YU H, Bonett S, Oyiborhoro U, Aryal S, et al
    Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
    PLoS One. 2024;19:e0305877.
    PubMed     Abstract available

  165. FERRIS BF, Balasubramanian S, Rajamanickam A, Munisankar S, et al
    Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.
    PLoS One. 2024;19:e0305819.
    PubMed     Abstract available

  166. YAZDANI Y, Pai P, Sayfi S, Mohammadi A, et al
    Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review.
    PLoS One. 2024;19:e0292143.
    PubMed     Abstract available

  167. SMITH DG, Smith CD, DeLeon JA, Sandoz JL, et al
    Factors influencing COVID-19 vaccine uptake among Latinos: A cross-sectional study.
    PLoS One. 2024;19:e0302332.
    PubMed     Abstract available

  168. BHATTACHARJEE A, Hosen MR, Lamisa AB, Ahammad I, et al
    An integrated comparative genomics, subtractive proteomics and immunoinformatics framework for the rational design of a Pan-Salmonella multi-epitope vaccine.
    PLoS One. 2024;19:e0292413.
    PubMed     Abstract available

  169. RAJI T, Fallah MP, Dereje N, Kakooza F, et al
    Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.
    PLoS One. 2024;19:e0306309.
    PubMed     Abstract available

  170. MAHARLOUEI N, Hosseinpour P, Erfani A, Shahriarirad R, et al
    Correction: Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.
    PLoS One. 2024;19:e0307336.
    PubMed     Abstract available

  171. TAREKE AA, Tewabe Ayelign A, Yewodiaw TK, Shiferaw EW, et al
    Retention rate of vaccination card and its associated factors among vaccinated children aged 12 horizontal line 23 months in Ethiopia: Multilevel logistic regression analysis.
    PLoS One. 2024;19:e0306421.
    PubMed     Abstract available

  172. AL-RASHDAN RA, Ta'an W, Mukattash T, Williams B, et al
    Maternal skepticism regarding children's vaccination in Jordan: Investigating the knowledge, attitude, and adherence.
    PLoS One. 2024;19:e0305209.
    PubMed     Abstract available

  173. MASUM MHU, Wajed S, Hossain MI, Moumi NR, et al
    An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches.
    PLoS One. 2024;19:e0305413.
    PubMed     Abstract available

  174. OLANI KUTA A, Dida N
    Covid-19 vaccine hesitancy and its predictors among diabetic patients on follow-up at public hospitals in Nekemte Town, Western Ethiopia.
    PLoS One. 2024;19:e0305200.
    PubMed     Abstract available

  175. ZEGEYE AF, Mekonen EG, Tekeba B, Alemu TG, et al
    Spatial distribution and determinants of measles vaccination dropout among under-five children in Ethiopia: A spatial and multilevel analysis of 2019 Ethiopian demographic and health survey.
    PLoS One. 2024;19:e0305393.
    PubMed     Abstract available

  176. SALAZAR JC, Vargas-Cely F, Garcia-Luna JA, Ramirez LG, et al
    Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia.
    PLoS One. 2024;19:e0307600.
    PubMed     Abstract available

  177. ZEHRA A, Jamil S, Farman M, Nisar KS, et al
    Modeling and analysis of Hepatitis B dynamics with vaccination and treatment with novel fractional derivative.
    PLoS One. 2024;19:e0307388.
    PubMed     Abstract available

  178. MANSOUR AA, Hussein SM, Felemban SG, Mahamid AW, et al
    Correction: Acceptance and hesitancy of parents to vaccinate children against coronavirus disease 2019 in Saudi Arabia.
    PLoS One. 2024;19:e0307674.
    PubMed     Abstract available

  179. QUEE FA, Hogema BM, Molier M, Slot E, et al
    The Elecsys(R) Anti-SARS-CoV-2 and Elecsys(R) Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
    PLoS One. 2024;19:e0305613.
    PubMed     Abstract available

  180. HOY C, Wood T, Moscoe E
    Correction: Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2024;19:e0307570.
    PubMed     Abstract available

  181. Retraction: Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
    PLoS One. 2024;19:e0307483.

  182. NOURANI L, Mehrizi AA, Zakeri S, Djadid ND, et al
    Correction: Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
    PLoS One. 2024;19:e0307447.
    PubMed     Abstract available

  183. LEE J, Lee CW, Suarez DL, Lee SA, et al
    Efficacy of commercial recombinant HVT vaccines against a North American clade H5N1 highly pathogenic avian influenza virus in chickens.
    PLoS One. 2024;19:e0307100.
    PubMed     Abstract available

  184. VAN DEN BOSSCHE J, De Laere M, Deschepper K, Germonpre P, et al
    Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study.
    PLoS One. 2024;19:e0307204.
    PubMed     Abstract available

    January 2023
  185. TESFA GA, Yehualashet DE, Getnet A, Bimer KB, et al
    Spatial distribution of complete basic childhood vaccination and associated factors among children aged 12-23 months in Ethiopia. A spatial and multilevel analysis.
    PLoS One. 2023;18:e0279399.
    PubMed     Abstract available

  186. ANZALONE AJ, Sun J, Vinson AJ, Beasley WH, et al
    Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative.
    PLoS One. 2023;18:e0279968.
    PubMed     Abstract available

  187. TESHALE AB, Amare T
    Exploring spatial variations and the individual and contextual factors of uptake of measles-containing second dose vaccine among children aged 24 to 35 months in Ethiopia.
    PLoS One. 2023;18:e0280083.
    PubMed     Abstract available

  188. KIM Y, Kim J, Li Y
    Did Massachusetts COVID-19 vaccine lottery increase vaccine uptake?
    PLoS One. 2023;18:e0279283.
    PubMed     Abstract available

  189. REIS AT, Camacho KG, Junqueira-Marinho MF, Gomes Junior SCDS, et al
    Trustworthiness of information sources on vaccines for COVID-19 prevention among Brazilians.
    PLoS One. 2023;18:e0279393.
    PubMed     Abstract available

  190. COVAS DT, de Jesus Lopes de Abreu A, Zampirolli Dias C, Vansan Ferreira R, et al
    Adverse events of COVID-19 vaccines in pregnant and postpartum women in Brazil: A cross-sectional study.
    PLoS One. 2023;18:e0280284.
    PubMed     Abstract available

  191. SHIRAHMADI S, Hazavehei SMM, Abbasi H, Otogara M, et al
    Effectiveness of online practical education on vaccination training in the students of bachelor programs during the Covid-19 pandemic.
    PLoS One. 2023;18:e0280312.
    PubMed     Abstract available

  192. BUNTING SR, Morris S, Chael J, Feinstein BA, et al
    Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students.
    PLoS One. 2023;18:e0280287.
    PubMed     Abstract available

  193. ARITA T, Suzuki Y, Shimasaki N, Kobayashi H, et al
    Identification of the properties of H5 influenza vaccine viruses with high hemagglutinin yields.
    PLoS One. 2023;18:e0280811.
    PubMed     Abstract available

  194. SCHNEIDER KA, Tsoungui Obama HCJ, Adil Mahmoud Yousif N
    A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    PLoS One. 2023;18:e0277505.
    PubMed     Abstract available

  195. CHO FN, Ngah YE, Tassang AN, Fru CN, et al
    Face mask ownership/utilisation and COVID-19 vaccine hesitancy amongst patients recovering from COVID-19 in Cameroon: A cross-sectional study.
    PLoS One. 2023;18:e0280269.
    PubMed     Abstract available

  196. NARTEY Y, Amo-Antwi K, Hill PC, Dassah ET, et al
    Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    PLoS One. 2023;18:e0280437.
    PubMed     Abstract available

  197. IZEOGU C, Gill E, Van Allen K, Williams N, et al
    Attitudes, perceptions, and preferences towards SARS CoV-2 testing and vaccination among African American and Hispanic public housing residents, New York City: 2020-2021.
    PLoS One. 2023;18:e0280460.
    PubMed     Abstract available

  198. VILLAVICENCIO A, Kelsey G, Nogueira NF, Zukerberg J, et al
    Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US.
    PLoS One. 2023;18:e0275141.
    PubMed     Abstract available

  199. CADDY C, Cheong M, Lim MSC, Power R, et al
    "Tell us what's going on": Exploring the information needs of pregnant and post-partum women in Australia during the pandemic with 'Tweets', 'Threads', and women's views.
    PLoS One. 2023;18:e0279990.
    PubMed     Abstract available

  200. DE FOUW M, Stroeken Y, Niwagaba B, Musheshe M, et al
    Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda.
    PLoS One. 2023;18:e0280052.
    PubMed     Abstract available

  201. KONTOS Z
    Reducing Vaccinia virus transmission indoors within 60 seconds: Applying SAFEAIR-X aerosol with Iodine-V as a disinfectant.
    PLoS One. 2023;18:e0279027.
    PubMed     Abstract available

  202. MERKELBACH I, Magnee T, Sana S, Kollmann J, et al
    Using the health belief model to explain COVID-19 vaccination hesitancy in Dutch urban citizens under thirty.
    PLoS One. 2023;18:e0279453.
    PubMed     Abstract available

  203. TAKAHASHI M, Saito K, Ai T, Nojiri S, et al
    Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
    PLoS One. 2023;18:e0279779.
    PubMed     Abstract available

  204. EMIRE MS, Shiferaw BZ
    Attitudes towards receiving COVID-19 vaccine and its associated factors among Southwest Ethiopian adults, 2021.
    PLoS One. 2023;18:e0280633.
    PubMed     Abstract available

  205. ONIFADE AA, Fowotade A, Rahamon SK, Edem VF, et al
    Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naive adult Nigerians.
    PLoS One. 2023;18:e0280276.
    PubMed     Abstract available

  206. ASADIAN M, Hassanzadeh SM, Safarchi A, Douraghi M, et al
    The effect of in vitro consecutive passages and culture medium on the genetic variations in BCG Pasteur 1173P2 vaccine.
    PLoS One. 2023;18:e0280294.
    PubMed     Abstract available

  207. DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
    Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    PLoS One. 2023;18:e0276423.
    PubMed     Abstract available

  208. PRAPHASIRI P, Prasert K, Shrestha M, Ditsungnoen D, et al
    Does prior vaccination affect the immune response to seasonal influenza vaccination among older adults? Findings from a prospective cohort study in a Northeastern Province of Thailand.
    PLoS One. 2023;18:e0279962.
    PubMed     Abstract available

  209. KINYILI M, Munyakazi JB, Mukhtar AYA
    Modeling the impact of combined use of COVID Alert SA app and vaccination to curb COVID-19 infections in South Africa.
    PLoS One. 2023;18:e0264863.
    PubMed     Abstract available

  210. LANGAT B, Muge EK, Night D, Okoth F, et al
    Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination schedules among outpatient clinic attendees in Nairobi.
    PLoS One. 2023;18:e0281256.
    PubMed     Abstract available

  211. ABAD N, Messinger SD, Huang Q, Hendrich MA, et al
    A qualitative study of behavioral and social drivers of COVID-19 vaccine confidence and uptake among unvaccinated Americans in the US April-May 2021.
    PLoS One. 2023;18:e0281497.
    PubMed     Abstract available

  212. LOHINIVA AL, Nurzhynska A, Mueed A, Ali A, et al
    Strengthening polio vaccine demand in Ghana: Understanding the factors influencing uptake of the vaccine and the effectiveness of different message frames.
    PLoS One. 2023;18:e0279809.
    PubMed     Abstract available

  213. PUSPITASARI M, Sattwika PD, Rahari DS, Wijaya W, et al
    Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281160.
    PubMed     Abstract available

  214. GAROFALO E, Biamonte F, Palmieri C, Battaglia AM, et al
    Severe and mild-moderate SARS-CoV-2 vaccinated patients show different frequencies of IFNgamma-releasing cells: An exploratory study.
    PLoS One. 2023;18:e0281444.
    PubMed     Abstract available

  215. KLOSE AM, Kosoy G, Miller BL
    Arrayed Imaging Reflectometry monitoring of anti-viral antibody production throughout vaccination and breakthrough Covid-19.
    PLoS One. 2023;18:e0277846.
    PubMed     Abstract available

  216. MARIANO IHM, Silva BF, Machado MDS, Blanco RM, et al
    Analysis of LruC lipoprotein and identification of peptides candidates for vaccine development and diagnosis of leptospirosis.
    PLoS One. 2023;18:e0281344.
    PubMed     Abstract available

  217. COLVIN KM, Camara KS, Adams LS, Sarpong AP, et al
    Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern Pennsylvania.
    PLoS One. 2023;18:e0280245.
    PubMed     Abstract available

  218. CHAMORRO G, Kawabata A, Carvalho MDG, Pimenta FC, et al
    Nasopharyngeal colonization by Streptococcus pneumoniae in children and adults before the introduction of the 10-valent conjugate vaccine, Paraguay.
    PLoS One. 2023;18:e0280722.
    PubMed     Abstract available

  219. LONCAREVIC GS, Jovanovic AL, Kanazir MS, Kisic Tepavcevic DB, et al
    Are pediatricians responsible for maintaining high MMR vaccination coverage? Nationwide survey on parental knowledge and attitudes towards MMR vaccine in Serbia.
    PLoS One. 2023;18:e0281495.
    PubMed     Abstract available

  220. YEO M, Seo J, Lim J
    The impact of the COVID-19 pandemic and the expansion of free vaccination policy on influenza vaccination coverage: An analysis of vaccination behavior in South Korea.
    PLoS One. 2023;18:e0281812.
    PubMed     Abstract available

  221. HORN M, Theilacker C, Sprenger R, von Eiff C, et al
    Mathematical modeling of pneumococcal transmission dynamics in response to PCV13 infant vaccination in Germany predicts increasing IPD burden due to serotypes included in next-generation PCVs.
    PLoS One. 2023;18:e0281261.
    PubMed     Abstract available

  222. CHOURPILIADIS C, Lovik A, Kahler AK, Valdimarsdottir UA, et al
    Short-term improvement of mental health after a COVID-19 vaccination.
    PLoS One. 2023;18:e0280587.
    PubMed     Abstract available

  223. LEONG DP, Zhang A, Breznik JA, Clare R, et al
    Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study.
    PLoS One. 2023;18:e0281673.
    PubMed     Abstract available

  224. AL-TAMIMI M, Tarifi AA, Qaqish A, Abbas MM, et al
    Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals.
    PLoS One. 2023;18:e0281689.
    PubMed     Abstract available

  225. HALDANE V, Ariyarajah A, Berry I, Loutet M, et al
    Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    PLoS One. 2023;18:e0281358.
    PubMed     Abstract available

  226. CORREA-PADILLA E, Hernandez-Cano A, Cuevas G, Acevedo-Betancur Y, et al
    Modifications in the piperazine ring of nucleozin affect anti-influenza activity.
    PLoS One. 2023;18:e0277073.
    PubMed     Abstract available

  227. ZHANG Q, Yi GY, Chen LP, He W, et al
    Sentiment analysis and causal learning of COVID-19 tweets prior to the rollout of vaccines.
    PLoS One. 2023;18:e0277878.
    PubMed     Abstract available

  228. ZEZELJ I, Petrovic M, Ivanovic A, Kurcubic P, et al
    I trust my immunity more than your vaccines: "Appeal to nature" bias strongly predicts questionable health behaviors in the COVID-19 pandemic.
    PLoS One. 2023;18:e0279122.
    PubMed     Abstract available

  229. BALLOUZ T, Menges D, Kaufmann M, Amati R, et al
    Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    PLoS One. 2023;18:e0281429.
    PubMed     Abstract available

  230. PARK MY, Park SY, Hartog A, van Hoffen E, et al
    Study protocol for cholera vaccination as a model to measure the inflammatory response in the gut: A case of modulation with a Lactobacillus plantarum K8 lysate.
    PLoS One. 2023;18:e0281817.
    PubMed     Abstract available

  231. CHEON S, Methiyothin T, Ahn I
    Analysis of COVID-19 vaccine adverse event using language model and unsupervised machine learning.
    PLoS One. 2023;18:e0282119.
    PubMed     Abstract available

  232. MANGAT HS, Rippon B, Reddy NT, Syed AA, et al
    Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.
    PLoS One. 2023;18:e0281993.
    PubMed     Abstract available

  233. SUPRENANT MP, Nyankesha E, Moreno-Garcia R, Buj V, et al
    Assessing the relationship between operationally defined zero-dose communities and access to selected primary healthcare services for children and pregnant women in emergency settings.
    PLoS One. 2023;18:e0281764.
    PubMed     Abstract available

  234. LO PRESTI A, Carannante A, Fazio C, Neri A, et al
    FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
    PLoS One. 2023;18:e0277976.
    PubMed     Abstract available

  235. BASHIR S, Phuoc NN, Herath T, Basit A, et al
    An oral pH-responsive Streptococcus agalactiae vaccine formulation provides protective immunity to pathogen challenge in tilapia: A proof-of-concept study.
    PLoS One. 2023;18:e0278277.
    PubMed     Abstract available

  236. NICHOL B, McCready JL, Steen M, Unsworth J, et al
    Barriers and facilitators of vaccine hesitancy for COVID-19, influenza, and pertussis during pregnancy and in mothers of infants under two years: An umbrella review.
    PLoS One. 2023;18:e0282525.
    PubMed     Abstract available

  237. COSTA-FONT J, Garcia-Hombrados J, Nicinska A
    The institutional origins of vaccines distrust: Evidence from former-Soviet countries.
    PLoS One. 2023;18:e0282420.
    PubMed     Abstract available

  238. RACHMAN A, Iriani A, Sukrisman L, Rajabto W, et al
    A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA.
    PLoS One. 2023;18:e0281907.
    PubMed     Abstract available

  239. HOVI P, Palmu AA, Nieminen TA, Artama M, et al
    Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study.
    PLoS One. 2023;18:e0282226.
    PubMed     Abstract available

  240. GANEM F, Folch C, Colom-Cadena A, Bordas A, et al
    Determinants of COVID-19 vaccine hesitancy among students and parents in Sentinel Schools Network of Catalonia, Spain.
    PLoS One. 2023;18:e0282871.
    PubMed     Abstract available

  241. MOMANI A, Hamaideh SH, Masadeh AB, Alhalaiqa F, et al
    The effect of COVID-19 vaccine tele-educational program on vaccine hesitancy and receiving the vaccine among women planning for pregnancy, pregnant or breast-feeding mothers.
    PLoS One. 2023;18:e0282627.
    PubMed     Abstract available

  242. ALATRANY SSJ, Falaiyah AM, Zuhairawi RHM, Ogden R, et al
    A cross-sectional analysis of the predictors of COVID-19 vaccine uptake and vaccine hesitancy in Iraq.
    PLoS One. 2023;18:e0282523.
    PubMed     Abstract available

  243. LIOZNOV D, Amosova I, Sheetikov SA, Zornikova KV, et al
    Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia.
    PLoS One. 2023;18:e0278878.
    PubMed     Abstract available

  244. RODRIGUEZ-AVIAL I, Garcia-Salguero C, Bermejo L, Teja J, et al
    Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents.
    PLoS One. 2023;18:e0282388.
    PubMed     Abstract available

  245. KOSIYAPORN H, Netrpukdee C, Pangkariya N, Chandrasiri O, et al
    The impact of vaccine information and other factors on COVID-19 vaccine acceptance in the Thai population.
    PLoS One. 2023;18:e0276238.
    PubMed     Abstract available

  246. WILLIAMS SN, Armitage CJ, Dienes K, Drury J, et al
    Public decisions about COVID-19 vaccines: A UK-based qualitative study.
    PLoS One. 2023;18:e0277360.
    PubMed     Abstract available

  247. ABIMBOLA TO, Van Handel M, Tie Y, Ouyang L, et al
    Cost-effectiveness of expanded hepatitis A vaccination among adults with diagnosed HIV, United States.
    PLoS One. 2023;18:e0282972.
    PubMed     Abstract available

  248. FISHMAN J, Mandell DS, Salmon MK, Candon M, et al
    Large and small financial incentives may motivate COVID-19 vaccination: A randomized, controlled survey experiment.
    PLoS One. 2023;18:e0282518.
    PubMed     Abstract available

  249. WAWERU KM, Omia DO, Kiganane L, Miroro O, et al
    Socio-economic and structural barriers in Newcastle disease vaccines uptake by smallholder women farmers in Southeastern Kenya.
    PLoS One. 2023;18:e0283076.
    PubMed     Abstract available

  250. SRIVASTAVA S, Verma S, Kamthania M, Saxena AK, et al
    Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health.
    PLoS One. 2023;18:e0282580.
    PubMed     Abstract available

  251. DHAKAL R, Shapkota S, Shrestha P, Adhikari P, et al
    Pregnant women's awareness, perception, and acceptability of COVID-19 vaccine attending antenatal clinics in Bharatpur, Nepal.
    PLoS One. 2023;18:e0278694.
    PubMed     Abstract available

  252. VAITHILINGAM S, Hwang LA, Nair M, Ng JWJ, et al
    COVID-19 vaccine hesitancy and its drivers: An empirical study of the vaccine hesitant group in Malaysia.
    PLoS One. 2023;18:e0282520.
    PubMed     Abstract available

  253. HONSKUS M, Krizova P, Okonji Z, Musilek M, et al
    Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
    PLoS One. 2023;18:e0282971.
    PubMed     Abstract available

  254. TAGHIOFF SM, Slavin BR, Mehra S, Holton T, et al
    The impact of influenza vaccination on surgical outcomes in COVID-19 positive patients: An analysis of 43,580 patients.
    PLoS One. 2023;18:e0281990.
    PubMed     Abstract available

  255. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    PubMed     Abstract available

  256. NAPIT R, Poudel A, Pradhan SM, Manandhar P, et al
    Newcastle disease burden in Nepal and efficacy of Tablet I2 vaccine in commercial and backyard poultry production.
    PLoS One. 2023;18:e0280688.
    PubMed     Abstract available

  257. NEIGHBORS CE, Sloane R, Pieper CF, Wixted D, et al
    Mitigation behavior prior to COVID-19 vaccination availability is associated with COVID-19 infection and time to vaccination.
    PLoS One. 2023;18:e0283381.
    PubMed     Abstract available

  258. KOLLAMPARAMBIL U, Oyenubi A, Nwosu C
    Mental distress, COVID19 vaccine distrust and vaccine hesitancy in South Africa: A causal mediation regression analysis.
    PLoS One. 2023;18:e0278218.
    PubMed     Abstract available

  259. YANG MC, Wang CC, Tang WC, Chen KM, et al
    Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies.
    PLoS One. 2023;18:e0283473.
    PubMed     Abstract available

  260. KUMAR R, Gupta M, Agarwal A, Mukherjee A, et al
    Epidemic efficacy of Covid-19 vaccination against Omicron: An innovative approach using enhanced residual recurrent neural network.
    PLoS One. 2023;18:e0280026.
    PubMed     Abstract available

  261. MAKI KO, Karlsson LC, Kaakinen JK, Schmid P, et al
    Tailoring interventions to suit self-reported format preference does not decrease vaccine hesitancy.
    PLoS One. 2023;18:e0283030.
    PubMed     Abstract available

  262. MCCREADY J, Comparcini D, Nichol B, Steen M, et al
    Understanding the barriers and facilitators of COVID-19 vaccine hesitancy amongst healthcare workers and healthcare students worldwide: An umbrella review protocol.
    PLoS One. 2023;18:e0283897.
    PubMed     Abstract available

  263. SIMMONS AE, Amoako A, Grima AA, Murison KR, et al
    Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study.
    PLoS One. 2023;18:e0283715.
    PubMed     Abstract available

  264. GOSLING J, Colbourn T
    What is associated with reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey.
    PLoS One. 2023;18:e0283760.
    PubMed     Abstract available

  265. ANDERSON R, Kim S, Roberts N, Petrou S, et al
    Systematic review of economic evaluations of varicella vaccination programmes.
    PLoS One. 2023;18:e0282327.
    PubMed     Abstract available

  266. MITTEREDER LR, Swoboda J, De Pascalis R, Elkins KL, et al
    IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice.
    PLoS One. 2023;18:e0283161.
    PubMed     Abstract available

  267. RADRIZZANI S, Fonseca C, Woollard A, Pettitt J, et al
    Both trust in, and polarization of trust in, relevant sciences have increased through the COVID-19 pandemic.
    PLoS One. 2023;18:e0278169.
    PubMed     Abstract available

  268. SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
    Multiple sclerosis and COVID-19: A retrospective study in Iran.
    PLoS One. 2023;18:e0283538.
    PubMed     Abstract available

  269. LI J, Nakagawa T, Kojima M, Nishikimi A, et al
    Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A cross-sectional study.
    PLoS One. 2023;18:e0283658.
    PubMed     Abstract available

  270. DOUCETTE EJ, Gray J, Fonseca K, Charlton C, et al
    A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study.
    PLoS One. 2023;18:e0284046.
    PubMed     Abstract available

  271. KRAUTMANN M, Davis B, Leroueil PR
    A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers.
    PLoS One. 2023;18:e0283977.
    PubMed     Abstract available

  272. MOHANTY S, Podmore B, Cunado Moral A, Matthews I, et al
    Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children
    PLoS One. 2023;18:e0283084.
    PubMed     Abstract available

  273. GOLOS AM, Guntuku SC, Piltch-Loeb R, Leininger LJ, et al
    Dear Pandemic: A topic modeling analysis of COVID-19 information needs among readers of an online science communication campaign.
    PLoS One. 2023;18:e0281773.
    PubMed     Abstract available

  274. ROY DN, Azam MS, Islam E
    Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.
    PLoS One. 2023;18:e0281395.
    PubMed     Abstract available

  275. ALMHEIRI S, Hazari A, Kumar P, Kumar S, et al
    A comprehensive survey on the beliefs, perceptions, and clinical manifestations of pre and post Covid-19 vaccinations among physiotherapy students in the United Arab Emirates.
    PLoS One. 2023;18:e0282385.
    PubMed     Abstract available

  276. MCCREADY JL, Nichol B, Steen M, Unsworth J, et al
    Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review.
    PLoS One. 2023;18:e0280439.
    PubMed     Abstract available

  277. ECKER UKH, Sharkey CXM, Swire-Thompson B
    Correcting vaccine misinformation: A failure to replicate familiarity or fear-driven backfire effects.
    PLoS One. 2023;18:e0281140.
    PubMed     Abstract available

  278. KYEI-ARTHUR F, Agyekum MW, Afrifa-Anane GF, Larbi RT, et al
    Perceptions about COVID-19 preventive measures among Ghanaian women.
    PLoS One. 2023;18:e0284362.
    PubMed     Abstract available

  279. MORRISON LTR, Anderson B, Brower A, Talbird SE, et al
    Macroeconomic impact of Ebola outbreaks in Sub-Saharan Africa and potential mitigation of GDP loss with prophylactic Ebola vaccination programs.
    PLoS One. 2023;18:e0283721.
    PubMed     Abstract available

  280. ANONUEVO LE, Lachica ZPT, Amistas DA, Lato JIE, et al
    Transmission dynamics and baseline epidemiological parameter estimates of Coronavirus disease 2019 pre-vaccination: Davao City, Philippines.
    PLoS One. 2023;18:e0283068.
    PubMed     Abstract available

  281. BOBADILLA ML, Villagra V, Ortiz V, Deluca G, et al
    High prevalence and co-infection of high-risk Human Papillomavirus genotypes among unvaccinated young women from Paraguay.
    PLoS One. 2023;18:e0283542.
    PubMed     Abstract available

  282. MARTINEZ-OLIVARES CE, Hernandez-Pando R, Mixcoha E
    In silico EsxG EsxH rational epitope selection: Candidate epitopes for vaccine design against pulmonary tuberculosis.
    PLoS One. 2023;18:e0284264.
    PubMed     Abstract available

  283. O'NEILL E, Brody AK, Ricketts T
    Inoculum source dependent effects of ericoid, mycorrhizal fungi on flowering and reproductive success in highbush blueberry (Vaccinium corymbosum).
    PLoS One. 2023;18:e0284631.
    PubMed     Abstract available

  284. UNDELIKWO VA, Shilton S, Folayan MO, Alaba O, et al
    COVID-19 self-testing in Nigeria: Stakeholders' opinions and perspectives on its value for case detection.
    PLoS One. 2023;18:e0282570.
    PubMed     Abstract available

  285. NI YH, Xu ZH, Wang J
    Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China.
    PLoS One. 2023;18:e0284810.
    PubMed     Abstract available

  286. MOHAMED NA, Solehan HM, Mohd Rani MD, Ithnin M, et al
    Understanding COVID-19 vaccine hesitancy in Malaysia: Public perception, knowledge, and acceptance.
    PLoS One. 2023;18:e0284973.
    PubMed     Abstract available

  287. DES JARLAIS DC, Lieff S, Grivel M, Meltzer G, et al
    COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources.
    PLoS One. 2023;18:e0283467.
    PubMed     Abstract available

  288. PRADO ADS, Kohls E, Baldofski S, Bianchi AS, et al
    How are Brazilian university students coping with the COVID-19 pandemic? Results of an online survey on psychosocial well-being, perceived burdens, and attitudes toward social distancing and vaccination.
    PLoS One. 2023;18:e0284190.
    PubMed     Abstract available

  289. KABAYIZA JC, Nilsson S, Andersson M
    Rotavirus infections and their genotype distribution in Rwanda before and after the introduction of rotavirus vaccination.
    PLoS One. 2023;18:e0284934.
    PubMed     Abstract available

  290. YAMANA TK, Galanti M, Pei S, Di Fusco M, et al
    The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.
    PLoS One. 2023;18:e0275699.
    PubMed     Abstract available

  291. MAHMOODI S, Amirzakaria JZ, Ghasemian A
    In silico design and validation of a novel multi-epitope vaccine candidate against structural proteins of Chikungunya virus using comprehensive immunoinformatics analyses.
    PLoS One. 2023;18:e0285177.
    PubMed     Abstract available

  292. TEYMOORZADEH M, Daneshfar N, Yazdanparast R
    Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats.
    PLoS One. 2023;18:e0284601.
    PubMed     Abstract available

  293. MAGEN H, Avigdor A, Nevo L, Fried S, et al
    Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders.
    PLoS One. 2023;18:e0284925.
    PubMed     Abstract available

  294. HALFON P, Jordana S, Blachier S, Cartlamy P, et al
    Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?
    PLoS One. 2023;18:e0281257.
    PubMed     Abstract available

  295. SUNTRONWONG N, Vichaiwattana P, Klinfueng S, Puenpa J, et al
    SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
    PLoS One. 2023;18:e0279147.
    PubMed     Abstract available

  296. LORIA J, Albani VVL, Coutinho FAB, Covas DT, et al
    Time-dependent vaccine efficacy estimation quantified by a mathematical model.
    PLoS One. 2023;18:e0285466.
    PubMed     Abstract available

  297. INTAWONG K, Chariyalertsak S, Chalom K, Wonghirundecha T, et al
    Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand.
    PLoS One. 2023;18:e0284130.
    PubMed     Abstract available

  298. KUZNETSOVA N, Siniavin A, Butenko A, Larichev V, et al
    Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus.
    PLoS One. 2023;18:e0284823.
    PubMed     Abstract available

  299. PRANIC SM, Vasanthan LT, Thompson JY, Mishra V, et al
    Protocol of a scoping review of systematic reviews and meta-analyses about COVID-19 vaccines and associated adverse events from vaccination.
    PLoS One. 2023;18:e0285442.
    PubMed     Abstract available

  300. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    PubMed     Abstract available

  301. ENGLER RJM, Montgomery JR, Spooner CE, Nelson MR, et al
    Myocarditis and pericarditis recovery following smallpox vaccine 2002-2016: A comparative observational cohort study in the military health system.
    PLoS One. 2023;18:e0283988.
    PubMed     Abstract available

  302. ROBINSON RE, Myerscough C, He N, Hill H, et al
    Comprehensive review of safety in Experimental Human Pneumococcal Challenge.
    PLoS One. 2023;18:e0284399.
    PubMed     Abstract available

  303. KONTOWICZ E, Moreno-Madrinan M, Ragland D, Beauvais W, et al
    A stochastic compartmental model to simulate intra- and inter-species influenza transmission in an indoor swine farm.
    PLoS One. 2023;18:e0278495.
    PubMed     Abstract available

  304. AMICK III BC, Allen JL, Brown CC, Goudie A, et al
    Racial differences in COVID-19 vaccine acceptance in Arkansas.
    PLoS One. 2023;18:e0268876.
    PubMed     Abstract available

  305. LYONS J, Nafilyan V, Akbari A, Bedston S, et al
    An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK.
    PLoS One. 2023;18:e0285979.
    PubMed     Abstract available

  306. PERMPIKUL P, Tongyoo S, Chaimayo C, Kanpai P, et al
    Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand.
    PLoS One. 2023;18:e0285737.
    PubMed     Abstract available

  307. ZAHARI M, Offeddu V, Smith GJD, Tam CC, et al
    Determinants of influenza and pneumococcal vaccine uptake among preschool children in Singapore.
    PLoS One. 2023;18:e0285561.
    PubMed     Abstract available

  308. COBB J, Soliman SSM, Retuerto M, Quijano JC, et al
    Changes in the gut microbiota of NOD mice in response to an oral Salmonella-based vaccine against type 1 diabetes.
    PLoS One. 2023;18:e0285905.
    PubMed     Abstract available

  309. BALOGUN FM, Bamgboye EA, Orimadegun AE
    Trends of infant vaccination timeliness and completion in selected urban slum communities in Ibadan, Southwestern Nigeria: A four-year review.
    PLoS One. 2023;18:e0285805.
    PubMed     Abstract available

  310. GATTI A, Zizzo G, De Paschale M, Tamburello A, et al
    Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
    PLoS One. 2023;18:e0285728.
    PubMed     Abstract available

  311. SANAMI S, Nazarian S, Ahmad S, Raeisi E, et al
    In silico design and immunoinformatics analysis of a universal multi-epitope vaccine against monkeypox virus.
    PLoS One. 2023;18:e0286224.
    PubMed     Abstract available

  312. QURESHI A, Syed Sulaiman SA, Rehman W, Mehmood A, et al
    Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan.
    PLoS One. 2023;18:e0285736.
    PubMed     Abstract available

  313. TENE L, Karasik A, Chodick G, Pereira DIA, et al
    Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.
    PLoS One. 2023;18:e0285606.
    PubMed     Abstract available

  314. STEFFENS MS, Bullivant B, Kaufman J, King C, et al
    Testing persuasive messages about booster doses of COVID-19 vaccines on intention to vaccinate in Australian adults: A randomised controlled trial.
    PLoS One. 2023;18:e0286799.
    PubMed     Abstract available

  315. MOUNIER-JACK S, Paterson P, Bell S, Letley L, et al
    Covid-19 vaccine roll-out in England: A qualitative evaluation.
    PLoS One. 2023;18:e0286529.
    PubMed     Abstract available

  316. ALI Z, Harastani H, Hammadi M, Reslan L, et al
    Erratum: Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
    PLoS One. 2023;18:e0286701.
    PubMed     Abstract available

  317. MASA'DEH R, Momani A, Rayan A, Hamaideh SH, et al
    COVID-19 vaccine hesitancy among women planning for pregnancy, pregnant or breastfeeding mothers in Jordan: A cross-sectional study.
    PLoS One. 2023;18:e0286289.
    PubMed     Abstract available

  318. JAY A, Kwilas SA, Josleyn M, Ricks K, et al
    Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA vaccine in rhesus macaques (Macaca mulatta) delivered using needle-free jet injection.
    PLoS One. 2023;18:e0275082.
    PubMed     Abstract available

  319. SCHRODER D, Muller F, Heesen G, Hummers E, et al
    Feasibility of self-organized blood sample collection in adults for study purposes in a primary care setting.
    PLoS One. 2023;18:e0286014.
    PubMed     Abstract available

  320. ISLAM MR, Haque MA, Ahamed B, Tanbir M, et al
    Assessment of vaccine perception and vaccination intention of Mpox infection among the adult males in Bangladesh: A cross-sectional study findings.
    PLoS One. 2023;18:e0286322.
    PubMed     Abstract available

  321. KABORE OD, Poda A, Ouattara CA, Michodigni FN, et al
    Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
    PLoS One. 2023;18:e0286665.
    PubMed     Abstract available

  322. RICK AM, Lentscher A, Xu L, Wilkins MS, et al
    Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
    PLoS One. 2023;18:e0287103.
    PubMed     Abstract available

  323. GOLEC M, Zembala-John J, Fronczek M, Konka A, et al
    Relationship between anthropometric and body composition parameters and anti-SARS-CoV-2 specific IgG titers in females vaccinated against COVID-19 according to the heterologous vaccination course: A cohort study.
    PLoS One. 2023;18:e0287128.
    PubMed     Abstract available

  324. RAJAMOORTHY Y, Taib NM, Harapan H, Wagner AL, et al
    Application of the double bounded dichotomous choice model to the estimation of parent's willingness to pay for the hand foot mouth disease vaccination: A survey in Selangor, Malaysia.
    PLoS One. 2023;18:e0286924.
    PubMed     Abstract available

  325. STOECKEL F, Thompson J, Szewach P, Stockli S, et al
    Correlates of support for international vaccine solidarity during the COVID-19 pandemic: Cross-sectional survey evidence from Germany.
    PLoS One. 2023;18:e0287257.
    PubMed     Abstract available

  326. HATCH BA, Kenzie E, Ramalingam N, Sullivan E, et al
    Impact of the COVID-19 vaccination mandate on the primary care workforce and differences between rural and urban settings to inform future policy decision-making.
    PLoS One. 2023;18:e0287553.
    PubMed     Abstract available

  327. PALMBORG A, Skovdal M, Molden T, Ahman H, et al
    Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics.
    PLoS One. 2023;18:e0287378.
    PubMed     Abstract available

  328. FERNANDEZ-SANCHEZ H, Zahoui Z, Jones J, Marfo EA, et al
    Access, acceptability, and uptake of the COVID-19 vaccine among global migrants: A rapid review.
    PLoS One. 2023;18:e0287884.
    PubMed     Abstract available

  329. GHAZAL S, Soyiri IN
    The effect of geographical variation in income measures on measles-mumps-rubella uptake and coverage in England; a protocol for an ecological study.
    PLoS One. 2023;18:e0280008.
    PubMed     Abstract available

  330. WIN SY, Murata S, Fujisawa S, Seo H, et al
    Characterization of cysteine proteases from poultry red mite, tropical fowl mite, and northern fowl mite to assess the feasibility of developing a broadly efficacious vaccine against multiple mite species.
    PLoS One. 2023;18:e0288565.
    PubMed     Abstract available

  331. SNYDER J, Zenone M
    Vaccine related crowdfunding on a 'Freedom Fundraising' platform.
    PLoS One. 2023;18:e0288539.
    PubMed     Abstract available

  332. RACEY CS, Donken R, Fox E, Porter I, et al
    Characterization of vaccine confidence among teachers in British Columbia, Canada: A population-based survey.
    PLoS One. 2023;18:e0288107.
    PubMed     Abstract available

  333. FELD Y, Hartmann AK
    Large-deviations of disease spreading dynamics with vaccination.
    PLoS One. 2023;18:e0287932.
    PubMed     Abstract available

  334. ADUGNA A, Demeke G, Toru M, Tsehay D, et al
    Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia.
    PLoS One. 2023;18:e0288355.
    PubMed     Abstract available

  335. BARAL P, Ahmed T, Amor Fernandez P, Peters MA, et al
    Vaccine hesitancy among healthcare workers in low- and middle-income countries during the COVID-19 pandemic: Results from facility surveys across six countries.
    PLoS One. 2023;18:e0288124.
    PubMed     Abstract available

  336. ZARABI N, Aldven M, Sjolander S, Fues Wahl H, et al
    Clinical and economic burden of pneumococcal disease among adults in Sweden: A population-based register study.
    PLoS One. 2023;18:e0287581.
    PubMed     Abstract available

  337. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    PubMed     Abstract available

  338. MOTAMEDI H, Alvandi A, Fathollahi M, Ari MM, et al
    In silico designing and immunoinformatics analysis of a novel peptide vaccine against metallo-beta-lactamase (VIM and IMP) variants.
    PLoS One. 2023;18:e0275237.
    PubMed     Abstract available

  339. SEPOTOKELE KM, O'Kennedy MM, Wandrag DBR, Abolnik C, et al
    Optimization of infectious bronchitis virus-like particle expression in Nicotiana benthamiana as potential poultry vaccines.
    PLoS One. 2023;18:e0288970.
    PubMed     Abstract available

  340. DUBE E, Trottier ME, Gagnon D, Bettinger JA, et al
    Exploring parents' views of the use of narratives to promote childhood vaccination online.
    PLoS One. 2023;18:e0284107.
    PubMed     Abstract available

  341. LUAN M, Qi Q, Shi W, Tao Z, et al
    Differential impacts of vaccine scandal by ethnic and socioeconomic factors: Evidence from China.
    PLoS One. 2023;18:e0288841.
    PubMed     Abstract available

  342. CUNHA NSP, de Olinda RA, Fahrat SCL, Barbieri CLA, et al
    Spatial analysis of vaccine coverage in children under the age of 1 year by mesoregions in Paraiba a northeastern Brazilian state.
    PLoS One. 2023;18:e0288651.
    PubMed     Abstract available

  343. MAYANJA Y, Rida W, Kimani J, Ssetala A, et al
    Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
    PLoS One. 2023;18:e0288604.
    PubMed     Abstract available

  344. LAOTEE S, Duangkaew M, Jivapetthai A, Tharakhet K, et al
    CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2.
    PLoS One. 2023;18:e0288486.
    PubMed     Abstract available

  345. AMELLAL H, Assaid N, Charoute H, Akarid K, et al
    Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
    PLoS One. 2023;18:e0288557.
    PubMed     Abstract available

  346. XIE Z, Qalati SA, Limon MLS, Sulaiman MABA, et al
    Understanding factors influencing healthcare workers' intention towards the COVID-19 vaccine.
    PLoS One. 2023;18:e0286794.
    PubMed     Abstract available

  347. BAM V, Mohammed A, Kusi-Amponsah A, Armah J, et al
    Caregivers' perception and acceptance of malaria vaccine for Children.
    PLoS One. 2023;18:e0288686.
    PubMed     Abstract available

  348. KIM S, Lee J, Yang H, Kim H, et al
    Acceptance of and hesitancy about COVID-19 vaccination among nursing students in clinical practice.
    PLoS One. 2023;18:e0286640.
    PubMed     Abstract available

  349. GENERAAL E, van Santen DKD, Campman SL, Booij MJ, et al
    Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands.
    PLoS One. 2023;18:e0288610.
    PubMed     Abstract available

  350. GRAM MA, Steenhard N, Cohen AS, Vangsted AM, et al
    Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up.
    PLoS One. 2023;18:e0281972.
    PubMed     Abstract available

  351. WARIRI O, Utazi CE, Okomo U, Sogur M, et al
    Timeliness of routine childhood vaccination among 12-35 months old children in The Gambia: Analysis of national immunisation survey data, 2019-2020.
    PLoS One. 2023;18:e0288741.
    PubMed     Abstract available

  352. KIKUT AI
    The doctor knows or the evidence shows: An online survey experiment testing the effects of source trust, pro-vaccine evidence, and dual-processing in expert messages recommending child COVID-19 vaccination to parents.
    PLoS One. 2023;18:e0288272.
    PubMed     Abstract available

  353. RYKOWSKA D, Sobierajski T, Okarska-Napierala M, Wanke-Rytt M, et al
    Influenza vaccination from the perspective of health care workers at university hospitals.
    PLoS One. 2023;18:e0288470.
    PubMed     Abstract available

  354. SCHNYDER SK, Molina JJ, Yamamoto R, Turner MS, et al
    Rational social distancing in epidemics with uncertain vaccination timing.
    PLoS One. 2023;18:e0288963.
    PubMed     Abstract available

  355. FERESHTEH S, Haririzadeh Jouriani F, Noori Goodarzi N, Torkamaneh M, et al
    Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology.
    PLoS One. 2023;18:e0289609.
    PubMed     Abstract available

  356. HERNANDEZ BAUTISTA PF, Grajales Muniz C, Cabrera Gaytan DA, Rojas Mendoza T, et al
    Impact of vaccination on infection or death from COVID-19 in individuals with laboratory-confirmed cases: Case-control study.
    PLoS One. 2023;18:e0265698.
    PubMed     Abstract available

  357. KOWATSCH MM, Lajoie J, Mwangi L, Omollo K, et al
    Hydroxychloroquine reduces T cells activation recall antigen responses.
    PLoS One. 2023;18:e0287738.
    PubMed     Abstract available

  358. VAN DEN BOOM W, van Dijk M, Snijders B, Luijben G, et al
    Cohort profile: The Corona Behavioral Unit cohort, a longitudinal mixed-methods study on COVID-19-related behavior, well-being and policy support in the Netherlands.
    PLoS One. 2023;18:e0289294.
    PubMed     Abstract available

  359. KIGONGO E, Kabunga A, Tumwesigye R, Musinguzi M, et al
    Prevalence and predictors of COVID-19 vaccination hesitancy among healthcare workers in Sub-Saharan Africa: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0289295.
    PubMed     Abstract available

  360. FROZANFAR MK, Hamajima N, Fayaz SH, Rahimzad AD, et al
    Factors associated with pentavalent vaccine coverage among 12-23-month-old children in Afghanistan: A cross-sectional study.
    PLoS One. 2023;18:e0289744.
    PubMed     Abstract available

  361. BATOOL R, Qureshi S, Haq Z, Yousafzai MT, et al
    Coverage survey of typhoid conjugate vaccine among children aged 6 months to 15 years in an urban slum settlement of Lyari Town Karachi, Pakistan.
    PLoS One. 2023;18:e0289582.
    PubMed     Abstract available

  362. ALHUDIRI I, Abusrewil Z, Dakhil O, Zwaik MA, et al
    Impact of vaccination and risk factors on COVID-19 mortality amid delta wave in Libya: A single center cohort study.
    PLoS One. 2023;18:e0289490.
    PubMed     Abstract available

  363. KURTZ SL, Ryden P, Elkins KL
    Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
    PLoS One. 2023;18:e0289358.
    PubMed     Abstract available

  364. SHEIKH NS, Touseef M, Sultan R, Cheema KH, et al
    Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    PLoS One. 2023;18:e0289678.
    PubMed     Abstract available

  365. JANG J, Jeong H, Kim BH, An S, et al
    Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea.
    PLoS One. 2023;18:e0290154.
    PubMed     Abstract available

  366. ALOYSIA D'COR N, Siddaiah P, Mohapatra S, Dhaded SM, et al
    Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
    PLoS One. 2023;18:e0284898.
    PubMed     Abstract available

  367. VANSTONE M, Correia RH, Howard M, Darling E, et al
    How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol.
    PLoS One. 2023;18:e0288952.
    PubMed     Abstract available

  368. SHAYEGH S, Andreu-Perez J, Akoth C, Bosch-Capblanch X, et al
    Prioritizing COVID-19 vaccine allocation in resource poor settings: Towards an Artificial Intelligence-enabled and Geospatial-assisted decision support framework.
    PLoS One. 2023;18:e0275037.
    PubMed     Abstract available

  369. YIN Z, Li M, Niu C, Yu M, et al
    Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS).
    PLoS One. 2023;18:e0286358.
    PubMed     Abstract available

  370. FADLYANA E, Dhamayanti M, Tarigan R, Prodjosoewojo S, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.
    PLoS One. 2023;18:e0281566.
    PubMed     Abstract available

  371. HOPKEN MW, Gilfillan D, Gilbert AT, Piaggio AJ, et al
    Biodiversity indices and Random Forests reveal the potential for striped skunk (Mephitis mephitis) fecal microbial communities to function as a biomarker for oral rabies vaccination.
    PLoS One. 2023;18:e0285852.
    PubMed     Abstract available

  372. GUPTA MD, Kunal S, M P G, Goyal D, et al
    Impact of COVID-19 vaccination on mortality after acute myocardial infarction.
    PLoS One. 2023;18:e0291090.
    PubMed     Abstract available

  373. SLOTKIN R, Kyriakides TC, Kundu A, Stack G, et al
    Correlation of a commercial platform's results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors.
    PLoS One. 2023;18:e0289713.
    PubMed     Abstract available

  374. MEUNIER M, Spillmann A, Rousseaux C, Schwamborn K, et al
    An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease.
    PLoS One. 2023;18:e0283489.
    PubMed     Abstract available

  375. LIU H, Han X, Lin X, Zhu X, et al
    Impact of vaccine measures on the transmission dynamics of COVID-19.
    PLoS One. 2023;18:e0290640.
    PubMed     Abstract available

  376. ZAVRAKLI E, Parnell A, Malone D, Duffy K, et al
    Optimal age-specific vaccination control for COVID-19: An Irish case study.
    PLoS One. 2023;18:e0290974.
    PubMed     Abstract available

  377. ZOLA MATUVANGA T, Marien J, Lariviere Y, Osang'ir BI, et al
    Low seroprevalence of Ebola virus in health care providers in an endemic region (Tshuapa province) of the Democratic Republic of the Congo.
    PLoS One. 2023;18:e0286479.
    PubMed     Abstract available

  378. SCALA A, Cavallo P
    Measuring the efficacy of a vaccine during an epidemic.
    PLoS One. 2023;18:e0290652.
    PubMed     Abstract available

  379. NYANDELE JP, Kibondo UA, Issa F, Van Geertruyden JP, et al
    Pre-vaccination monocyte-to-lymphocyte ratio as a biomarker for the efficacy of malaria candidate vaccines: A subgroup analysis of pooled clinical trial data.
    PLoS One. 2023;18:e0291244.
    PubMed     Abstract available

  380. MOIN AT, Rani NA, Ullah MA, Patil RB, et al
    An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
    PLoS One. 2023;18:e0287416.
    PubMed     Abstract available

  381. NARANJO D, Kimball E, Nelson J, Samore M, et al
    Differences in perceptions and acceptance of COVID-19 vaccination between vaccine hesitant and non-hesitant persons.
    PLoS One. 2023;18:e0290540.
    PubMed     Abstract available

  382. HU W, Jia N, Meng W, Zhou T, et al
    Safety analysis of a live attenuated mumps vaccine in healthy adolescents in China: A phase 4, observational, open-label trial.
    PLoS One. 2023;18:e0291730.
    PubMed     Abstract available

  383. STERNBERG MR, Johnson A, King J, Ali AR, et al
    Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.
    PLoS One. 2023;18:e0291678.
    PubMed     Abstract available

  384. LENDE SSF, Barnkob NM, Hansen RW, Bansia H, et al
    Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster.
    PLoS One. 2023;18:e0291131.
    PubMed     Abstract available

  385. MURPHY R, Pomerantz L, Kuruppumullage Don P, Sung Kim J, et al
    Age and political leaning predict COVID-19 vaccination status at a large, multi-campus, public university in Pennsylvania: A cross-sectional survey.
    PLoS One. 2023;18:e0291974.
    PubMed     Abstract available

  386. TAKAHASHI T, Ai T, Saito K, Nojiri S, et al
    Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination.
    PLoS One. 2023;18:e0291670.
    PubMed     Abstract available

  387. Editorial Note: School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits.
    PLoS One. 2023;18:e0291903.

  388. EVANS WD, Bingenheimer JB, Long M, Ndiaye K, et al
    Outcomes of a social media campaign to promote COVID-19 vaccination in Nigeria.
    PLoS One. 2023;18:e0290757.
    PubMed     Abstract available

  389. LAO T, Avalos I, Rodriguez EM, Zamora Y, et al
    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.
    PLoS One. 2023;18:e0288006.
    PubMed     Abstract available

  390. KATZMAN C, Morgan T, de Roche A, Harris J, et al
    Longitudinal assessment of COVID-19 vaccine uptake: A two-wave survey of a nationally representative U.S. sample.
    PLoS One. 2023;18:e0289541.
    PubMed     Abstract available

  391. KALITA N, Corr PG, Ward MC, Xavier J, et al
    Identifying facilitators and barriers to culturally responsive communication for racial, ethnic, sexual, and gender minoritized patients when screened for COVID-19 vaccinations: A scoping review protocol.
    PLoS One. 2023;18:e0290514.
    PubMed     Abstract available

  392. YUSUF M, Destiarani W, Widayat W, Yosua Y, et al
    Coarse-grained molecular dynamics-guided immunoinformatics to explain the binder and non-binder classification of Cytotoxic T-cell epitope for SARS-CoV-2 peptide-based vaccine discovery.
    PLoS One. 2023;18:e0292156.
    PubMed     Abstract available

  393. PEREZ CHACON G, Fathima P, Jones M, Estcourt MJ, et al
    Association between pertussis vaccination in infancy and childhood asthma: A population-based record linkage cohort study.
    PLoS One. 2023;18:e0291483.
    PubMed     Abstract available

  394. AQUINO VH, Fumagalli MJ, Silva A, de Moura Negrini BV, et al
    Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: Prospection of peptides for vaccines and diagnostics.
    PLoS One. 2023;18:e0292451.
    PubMed     Abstract available

  395. MATHEW JL, Wagner AL, Ratho RK, Patel PN, et al
    Maternally transmitted anti-measles antibodies, and susceptibility to disease among infants in Chandigarh, India: A prospective birth cohort study.
    PLoS One. 2023;18:e0287110.
    PubMed     Abstract available

  396. FRANCESCHI J, Pareschi L, Bellodi E, Gavanelli M, et al
    Modeling opinion polarization on social media: Application to Covid-19 vaccination hesitancy in Italy.
    PLoS One. 2023;18:e0291993.
    PubMed     Abstract available

  397. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    PubMed     Abstract available

  398. RAVINDRAN R, Kang H, McReynolds C, Sanghar GK, et al
    Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines.
    PLoS One. 2023;18:e0287377.
    PubMed     Abstract available

  399. DEMSASH AW, Chereka AA, Walle AD, Kassie SY, et al
    Machine learning algorithms' application to predict childhood vaccination among children aged 12-23 months in Ethiopia: Evidence 2016 Ethiopian Demographic and Health Survey dataset.
    PLoS One. 2023;18:e0288867.
    PubMed     Abstract available

  400. TURMUKHAMBETOVA A, Yegorov S, Korshukov I, Barkhanskaya V, et al
    The impact of Gam-COVID-Vac, an Adv5/Adv26 COVID-19 vaccine, on the biomarkers of endothelial function, coagulation and platelet activation.
    PLoS One. 2023;18:e0293074.
    PubMed     Abstract available

  401. BUTT AIK, Imran M, Aslam J, Batool S, et al
    Computational analysis of control of hepatitis B virus disease through vaccination and treatment strategies.
    PLoS One. 2023;18:e0288024.
    PubMed     Abstract available

  402. PENOT P, Chateauneuf J, Auperin I, Cordel H, et al
    Socioeconomic impact of the COVID-19 crisis and early perceptions of COVID-19 vaccines among immigrant and nonimmigrant people living with HIV followed up in public hospitals in Seine-Saint-Denis, France.
    PLoS One. 2023;18:e0276038.
    PubMed     Abstract available

  403. LEUNG V, Gill S, Llanes A, Khawaja A, et al
    A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir-Ritonavir for COVID-19 in an interdisciplinary community clinic.
    PLoS One. 2023;18:e0293302.
    PubMed     Abstract available

  404. BAKKABULINDI P, Ampeire I, Ayebale L, Mubiri P, et al
    Engagement of community health workers to improve immunization coverage through addressing inequities and enhancing data quality and use is a feasible and effective approach: An implementation study in Uganda.
    PLoS One. 2023;18:e0292053.
    PubMed     Abstract available

  405. DARAMOLA T, Szatkowski L
    Association between women's experience of domestic violence and childhood vaccination in West Africa: Cross-sectional analysis of Demographic and Health Survey data.
    PLoS One. 2023;18:e0293900.
    PubMed     Abstract available

  406. HAU D, Pflughoeft KJ, Gates-Hollingsworth MA, Kaur S, et al
    Serum antibody levels to SARS-CoV-2 receptor-binding domain (RBD) in convalescent patients and vaccinated individuals of northern Nevada.
    PLoS One. 2023;18:e0288713.
    PubMed     Abstract available

  407. MORADPOUR J, Shajarizadeh A, Carter J, Chit A, et al
    The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
    PLoS One. 2023;18:e0293184.
    PubMed     Abstract available

  408. FEODOROVA VA, Zaitsev SS, Lyapina AM, Kichemazova NV, et al
    Whole genome sequencing characteristics of Chlamydia psittaci caprine AMK-16 strain, a promising killed whole cell veterinary vaccine candidate against chlamydia infection.
    PLoS One. 2023;18:e0293612.
    PubMed     Abstract available

  409. KASWANDANI N, Medise BE, Leonard E, Satari HI, et al
    Safety profile of inactivated COVID-19 in healthy adults aged >/= 18 years: A passive surveillance in Indonesia.
    PLoS One. 2023;18:e0286484.
    PubMed     Abstract available

  410. MAHUMUD RA, Alam K, Afroz S, Ormsby GM, et al
    Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.
    PLoS One. 2023;18:e0294379.
    PubMed     Abstract available

  411. SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
    Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria.
    PLoS One. 2023;18:e0293449.
    PubMed     Abstract available

  412. NASIRATU I, Pencille LB, Khuzwayo N, Aboagye RG, et al
    Predictors of COVID-19 vaccine uptake among persons aged 18 years and above in Ga North Municipality, Ghana using the Health Belief Model: A community-based cross-sectional study.
    PLoS One. 2023;18:e0293350.
    PubMed     Abstract available

  413. NAQID IA, Mosa AA, Ibrahim SV, Ibrahim NH, et al
    Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study.
    PLoS One. 2023;18:e0293822.
    PubMed     Abstract available

  414. WEAVER KL, Bitzer GJ, Wolf MA, Pyles GM, et al
    Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
    PLoS One. 2023;18:e0286925.
    PubMed     Abstract available

  415. BOLOTIN S, Hughes SL, Savage RD, McLachlan E, et al
    Maternal varicella antibodies in children aged less than one year: Assessment of antibody decay.
    PLoS One. 2023;18:e0287765.
    PubMed     Abstract available

  416. FATIMA S, Ismail M, Ejaz T, Shah Z, et al
    Association between long COVID and vaccination: A 12-month follow-up study in a low- to middle-income country.
    PLoS One. 2023;18:e0294780.
    PubMed     Abstract available

  417. AIMAN S, Ahmad A, Khan A, Ali Y, et al
    Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches.
    PLoS One. 2023;18:e0289773.
    PubMed     Abstract available

  418. KLAESSON J, Lobo J, Mellander C
    Social interactions and COVID-19 vaccine hesitancy: Evidence from a full population study in Sweden.
    PLoS One. 2023;18:e0289309.
    PubMed     Abstract available

  419. MWILA-KAZIMBAYA K, Bosomprah S, Chilyabanyama ON, Chisenga CC, et al
    Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach.
    PLoS One. 2023;18:e0293101.
    PubMed     Abstract available

  420. WUBSHET E, Dagnaw A, Gebrelibanos H, Tefera M, et al
    Assessment of COVID-19 vaccine acceptance and its associated factors in Debre Berhan City, Ethiopia, 2022.
    PLoS One. 2023;18:e0288321.
    PubMed     Abstract available

  421. GHOSH S, Ogueda-Oliva A, Ghosh A, Banerjee M, et al
    Understanding the implications of under-reporting, vaccine efficiency and social behavior on the post-pandemic spread using physics informed neural networks: A case study of China.
    PLoS One. 2023;18:e0290368.
    PubMed     Abstract available

  422. O'REILLY S, Kenny G, Alrawahneh T, Francois N, et al
    Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening.
    PLoS One. 2023;18:e0294262.
    PubMed     Abstract available

  423. MENA G, Casas I, Casan C, Aunon M, et al
    Correction: Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    PLoS One. 2023;18:e0295454.
    PubMed     Abstract available

  424. KASAHUN AW, Zewdie A, Mose A, Adane HA, et al
    Health professionals' knowledge on vaccine cold chain management and associated factors in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2023;18:e0293122.
    PubMed     Abstract available

    Obscured inequity: How focusing on rates of disparities can conceal inequities in the reasons why adolescents are unvaccinated.
    PLoS One. 2023;18:e0293928.
    PubMed     Abstract available

  426. Correction: Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
    PLoS One. 2023;18:e0295159.
    PubMed     Abstract available

  427. KIM SE, Park SH, Park WJ, Kim G, et al
    Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.
    PLoS One. 2023;18:e0295594.
    PubMed     Abstract available

  428. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2023;18:e0295688.
    PubMed     Abstract available

  429. FRANCISCO AG, Reyes JCB, Tabios IKB, Cruz CJG, et al
    Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines.
    PLoS One. 2023;18:e0293046.
    PubMed     Abstract available

  430. MAYITO J, Meya DB, Miriam A, Dhikusooka F, et al
    Monocyte to Lymphocyte ratio is highly specific in diagnosing latent tuberculosis and declines significantly following tuberculosis preventive therapy: A cross-sectional and nested prospective observational study.
    PLoS One. 2023;18:e0291834.
    PubMed     Abstract available

  431. PARKER CH, Sadhir S, Swanson Z, McGrosky A, et al
    Effect of influenza vaccination on resting metabolic rate and c-reactive protein concentrations in healthy young adults.
    PLoS One. 2023;18:e0295540.
    PubMed     Abstract available

  432. MILANI B, Dos Santos TW, Guerra MES, Oliveira S, et al
    Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage.
    PLoS One. 2023;18:e0291203.
    PubMed     Abstract available

  433. ANWAR T, Ismail S, Parvaiz F, Abbasi SW, et al
    Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach.
    PLoS One. 2023;18:e0294663.
    PubMed     Abstract available

  434. ZAKHOUR R, Tamim H, Faytrouni F, Makki M, et al
    Determinants of human papillomavirus vaccine hesitancy among Lebanese parents.
    PLoS One. 2023;18:e0295644.
    PubMed     Abstract available

  435. SACRE A, Bambra C, Wildman JM, Thomson K, et al
    Socioeconomic inequalities in vaccine uptake: A global umbrella review.
    PLoS One. 2023;18:e0294688.
    PubMed     Abstract available

  436. MOIN AT, Rani NA, Ullah MA, Patil RB, et al
    Correction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
    PLoS One. 2023;18:e0295830.
    PubMed     Abstract available

  437. BATMUNKH B, Otgonbayar D, Shaarii S, Khaidav N, et al
    RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia.
    PLoS One. 2023;18:e0295167.
    PubMed     Abstract available

  438. BRODY C, Szieff J, Abu-Alrub B
    "If it wasn't forced upon me, I would have given it a second thought": Understanding COVID-19 vaccine hesitancy in an outlier county in the Bay Area, California.
    PLoS One. 2023;18:e0290469.
    PubMed     Abstract available

  439. KRASTEV S, Krajden O, Vang ZM, Perez-Gay Juarez F, et al
    Navigating the uncertainty: A novel taxonomy of vaccine hesitancy in the context of COVID-19.
    PLoS One. 2023;18:e0295912.
    PubMed     Abstract available

  440. PATWARY MM, Disha AS, Hasan M, Bardhan M, et al
    Integrating health belief model and theory of planned behavior to assess COVID-19 vaccine acceptance among urban slum people in Bangladesh.
    PLoS One. 2023;18:e0290412.
    PubMed     Abstract available

  441. BIRHANU F, Yitbarek K
    Wealth-based inequity in full child vaccination coverage: An experience from Mali, Bangladesh, and South Africa. A multilevel poison regression.
    PLoS One. 2023;18:e0293522.
    PubMed     Abstract available

  442. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    PubMed     Abstract available

  443. MACGREGOR-FAIRLIE M, De Gomes P, Weston D, Rickard JJS, et al
    Hybrid use of Raman spectroscopy and artificial neural networks to discriminate Mycobacterium bovis BCG and other Mycobacteriales.
    PLoS One. 2023;18:e0293093.
    PubMed     Abstract available

  444. FARRENKOPF BA, Zhou X, Shet A, Olayinka F, et al
    Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries.
    PLoS One. 2023;18:e0287459.
    PubMed     Abstract available

    January 2022
  445. BAJOS N, Spire A, Silberzan L
    The social specificities of hostility toward vaccination against Covid-19 in France.
    PLoS One. 2022;17:e0262192.
    PubMed     Abstract available

  446. PATEL SM, Shaik-Dasthagirisaheb YB, Congdon M, Young RR, et al
    Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2022;17:e0262225.
    PubMed     Abstract available

  447. NG OMBE H, Simuyandi M, Mwaba J, Luchen CC, et al
    Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol) in adults residing in Lukanga Swamps of Zambia.
    PLoS One. 2022;17:e0262239.
    PubMed     Abstract available

  448. RINTA-KOKKO H, Palmu AA, Ruokokoski E, Nieminen H, et al
    Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial.
    PLoS One. 2022;17:e0261750.
    PubMed     Abstract available

  449. YOUNG-XU Y, Smith J, Nealon J, Mahmud SM, et al
    Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans.
    PLoS One. 2022;17:e0262072.
    PubMed     Abstract available

  450. LEE C, Holroyd TA, Gur-Arie R, Sauer M, et al
    COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy.
    PLoS One. 2022;17:e0261929.
    PubMed     Abstract available

  451. AKTHER T, Nur T
    A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use.
    PLoS One. 2022;17:e0261869.
    PubMed     Abstract available

  452. GHADDAR A, Khandaqji S, Awad Z, Kansoun R, et al
    Conspiracy beliefs and vaccination intent for COVID-19 in an infodemic.
    PLoS One. 2022;17:e0261559.
    PubMed     Abstract available

  453. SIEWE N, Friedman A
    Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model.
    PLoS One. 2022;17:e0262453.
    PubMed     Abstract available

  454. TEERAWATTANANON Y, Anothaisintawee T, Pheerapanyawaranun C, Botwright S, et al
    A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.
    PLoS One. 2022;17:e0261930.
    PubMed     Abstract available

  455. SEO J, Lim J
    The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019.
    PLoS One. 2022;17:e0262594.
    PubMed     Abstract available

  456. STRICKLAND JC, Reed DD, Hursh SR, Schwartz LP, et al
    Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic.
    PLoS One. 2022;17:e0258828.
    PubMed     Abstract available

  457. WISNEWSKI AV, Liu J, Lucas C, Klein J, et al
    Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
    PLoS One. 2022;17:e0262657.
    PubMed     Abstract available

  458. YOKOTA H, Hayashi H, Hanaguri J, Yamagami S, et al
    Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes.
    PLoS One. 2022;17:e0262568.
    PubMed     Abstract available

  459. DIRIRSA K, Makuria M, Mulu E, Deriba BS, et al
    Assessment of vaccination timeliness and associated factors among children in Toke Kutaye district, central Ethiopia: A Mixed study.
    PLoS One. 2022;17:e0262320.
    PubMed     Abstract available

  460. RAUT S, Apte A, Srinivasan M, Dudeja N, et al
    Determinants of maternal influenza vaccination in the context of low- and middle-income countries: A systematic review.
    PLoS One. 2022;17:e0262871.
    PubMed     Abstract available

  461. MOSE A, Haile K, Timerga A
    COVID-19 vaccine hesitancy among medical and health science students attending Wolkite University in Ethiopia.
    PLoS One. 2022;17:e0263081.
    PubMed     Abstract available

  462. RAMATILLAH DL, Gan SH, Pratiwy I, Syed Sulaiman SA, et al
    Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.
    PLoS One. 2022;17:e0262438.
    PubMed     Abstract available

  463. LIAO CC, Tai YH, Yeh CC, Hsu YH, et al
    Effect of influenza vaccination on the outcomes of hospitalization for kidney disease in a geriatric population: A propensity-score matched study.
    PLoS One. 2022;17:e0262420.
    PubMed     Abstract available

  464. AMINUDDIN F, Zaimi NA, Mohd Nor Sham Kunusagaran MSJ, Bahari MS, et al
    Cost-effectiveness and budget impact analysis of PPV23 vaccination for the Malaysian Hajj pilgrims.
    PLoS One. 2022;17:e0262949.
    PubMed     Abstract available

  465. BELL S, Clarke RM, Ismail SA, Ojo-Aromokudu O, et al
    COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study.
    PLoS One. 2022;17:e0260949.
    PubMed     Abstract available

  466. NERY N JR, Ticona JPA, Cardoso CW, Prates APPB, et al
    COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.
    PLoS One. 2022;17:e0262649.
    PubMed     Abstract available

  467. NISAR MI, Jehan F, Shahid S, Ahmed S, et al
    Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan.
    PLoS One. 2022;17:e0262466.
    PubMed     Abstract available

  468. OCAN M, Acheng F, Otike C, Beinomugisha J, et al
    Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda.
    PLoS One. 2022;17:e0262126.
    PubMed     Abstract available

  469. KORANG SK, von Rohden E, Veroniki AA, Ong G, et al
    Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
    PLoS One. 2022;17:e0260733.
    PubMed     Abstract available

  470. OHMURA H
    Analysis of social combinations of COVID-19 vaccination: Evidence from a conjoint analysis.
    PLoS One. 2022;17:e0261426.
    PubMed     Abstract available

  471. CHEN PY, Chuang PN, Chiang CH, Chang HH, et al
    Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization-A community-based questionnaire study.
    PLoS One. 2022;17:e0262660.
    PubMed     Abstract available

  472. TLALE LB, Gabaitiri L, Totolo LK, Smith G, et al
    Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    PLoS One. 2022;17:e0263375.
    PubMed     Abstract available

  473. PETROVIC V, Vukovic V, Patic A, Markovic M, et al
    Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.
    PLoS One. 2022;17:e0263468.
    PubMed     Abstract available

  474. BEARTH A, Berthold A, Siegrist M
    People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats.
    PLoS One. 2022;17:e0263351.
    PubMed     Abstract available

  475. VOIGT A, Omholt S, Almaas E
    Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    PLoS One. 2022;17:e0263155.
    PubMed     Abstract available

  476. PRATAMA NR, Wafa IA, Budi DS, Putra M, et al
    mRNA Covid-19 vaccines in pregnancy: A systematic review.
    PLoS One. 2022;17:e0261350.
    PubMed     Abstract available

  477. RONCHINI C, Gandini S, Pasqualato S, Mazzarella L, et al
    Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs.
    PLoS One. 2022;17:e0263014.
    PubMed     Abstract available

  478. MEMIRIE ST, Yigezu A, Zewdie SA, Mirkuzie AH, et al
    Hospitalization costs for COVID-19 in Ethiopia: Empirical data and analysis from Addis Ababa's largest dedicated treatment center.
    PLoS One. 2022;17:e0260930.
    PubMed     Abstract available

  479. JANOWSKI AB, Polgreen PM, Beekmann SE, Newland JG, et al
    Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey.
    PLoS One. 2022;17:e0263767.
    PubMed     Abstract available

  480. MAOR Y, Caspi S
    Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population.
    PLoS One. 2022;17:e0255495.
    PubMed     Abstract available

  481. HOSSIAN M, Khan MAS, Nazir A, Nabi MH, et al
    Factors affecting intention to take COVID-19 vaccine among Pakistani University Students.
    PLoS One. 2022;17:e0262305.
    PubMed     Abstract available

  482. DAVIS B, Krautmann M, Leroueil PR
    A method for estimating the impact of new vaccine technologies on vaccination coverage rates.
    PLoS One. 2022;17:e0263612.
    PubMed     Abstract available

  483. BASSI J, Giannini O, Silacci-Fregni C, Pertusini L, et al
    Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
    PLoS One. 2022;17:e0263328.
    PubMed     Abstract available

  484. ALHENDYANI F, Jolly K, Jones LL
    Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis.
    PLoS One. 2022;17:e0263234.
    PubMed     Abstract available

  485. MONSTED B, Lehmann S
    Characterizing polarization in online vaccine discourse-A large-scale study.
    PLoS One. 2022;17:e0263746.
    PubMed     Abstract available

  486. SINGH K, Lima G, Cha M, Cha C, et al
    Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic.
    PLoS One. 2022;17:e0263381.
    PubMed     Abstract available

  487. JUNG BK, An YH, Jang JJ, Jeon JH, et al
    The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate.
    PLoS One. 2022;17:e0263684.
    PubMed     Abstract available

  488. EGLOFF C, Couffignal C, Cordier AG, Deruelle P, et al
    Pregnant women's perceptions of the COVID-19 vaccine: A French survey.
    PLoS One. 2022;17:e0263512.
    PubMed     Abstract available

  489. ZHOU L, Ampon-Wireko S, Xu X, Quansah PE, et al
    Media attention and Vaccine Hesitancy: Examining the mediating effects of Fear of COVID-19 and the moderating role of Trust in leadership.
    PLoS One. 2022;17:e0263610.
    PubMed     Abstract available

  490. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: Prevision vs. reality of Bangladesh context.
    PLoS One. 2022;17:e0263078.
    PubMed     Abstract available

  491. LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
    Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults.
    PLoS One. 2022;17:e0264062.
    PubMed     Abstract available

  492. JAMISON AF, McCormick BJJ, Hussain E, Thomas ED, et al
    Determinants of vaccine coverage and timeliness in a northern Pakistani village.
    PLoS One. 2022;17:e0263712.
    PubMed     Abstract available

  493. ROBERTS HA, Clark DA, Kalina C, Sherman C, et al
    To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability.
    PLoS One. 2022;17:e0264019.
    PubMed     Abstract available

  494. KANE PB, Moyer H, MacPherson A, Papenburg J, et al
    Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USA.
    PLoS One. 2022;17:e0262740.
    PubMed     Abstract available

  495. DIEHL C, Hunkler C
    Vaccination-related attitudes and behavior across birth cohorts: Evidence from Germany.
    PLoS One. 2022;17:e0263871.
    PubMed     Abstract available

  496. BUDZIAR W, Gembara K, Harhala M, Szymczak A, et al
    Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    PLoS One. 2022;17:e0253638.
    PubMed     Abstract available

  497. ENYEW EB, Tareke AA
    Vaccination status and factors associated among children age 12-23 months in Ethiopia, based on 2016 EDHS: Logit based multinomial logistic regression analysis.
    PLoS One. 2022;17:e0264004.
    PubMed     Abstract available

  498. ADEDEJI-ADENOLA H, Olugbake OA, Adeosun SA
    Factors influencing COVID-19 vaccine uptake among adults in Nigeria.
    PLoS One. 2022;17:e0264371.
    PubMed     Abstract available

  499. MAMUTI S, Tabu C, Marete I, Opili D, et al
    Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya.
    PLoS One. 2022;17:e0263780.
    PubMed     Abstract available

  500. YOUSSEF D, Abou-Abbas L, Berry A, Youssef J, et al
    Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model.
    PLoS One. 2022;17:e0264128.
    PubMed     Abstract available

  501. BSOUL EA, Loomer PM
    COVID-19 vaccination experience among United States dental professionals and students: Safety, confidence, concerns, and side effects.
    PLoS One. 2022;17:e0264323.
    PubMed     Abstract available

  502. BONHOMME ME, Bonhomme CJ, Strelow L, Chaudhari A, et al
    Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
    PLoS One. 2022;17:e0262922.
    PubMed     Abstract available

  503. LI H, Ren H, Zhou Y, Zhang Y, et al
    HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice.
    PLoS One. 2022;17:e0262231.
    PubMed     Abstract available

  504. ACKHTER MM, Shahid ASMSB, Ahmed T, Palit P, et al
    Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guerin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.
    PLoS One. 2022;17:e0262391.
    PubMed     Abstract available

  505. STRUPAT C, Shigute Z, Bedi AS, Rieger M, et al
    Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    PLoS One. 2022;17:e0264633.
    PubMed     Abstract available

  506. ROMERO-IBARGUENGOITIA ME, Rivera-Salinas D, Hernandez-Ruiz YG, Armendariz-Vazquez AG, et al
    Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.
    PLoS One. 2022;17:e0263942.
    PubMed     Abstract available

  507. PAVIC Z, Suljok A
    Vaccination conspiracy beliefs among social science & humanities and STEM educated people-An analysis of the mediation paths.
    PLoS One. 2022;17:e0264722.
    PubMed     Abstract available

  508. FOJNICA A, Osmanovic A, Duzic N, Fejzic A, et al
    COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina.
    PLoS One. 2022;17:e0264754.
    PubMed     Abstract available

  509. SANDOR J, Vincze F, Shrikant ML, Korosi L, et al
    COVID-19 vaccination coverage in deprived populations living in segregated colonies: A nationwide cross-sectional study in Hungary.
    PLoS One. 2022;17:e0264363.
    PubMed     Abstract available

  510. TSUNETSUGU-YOKOTA Y, Ito S, Adachi Y, Onodera T, et al
    Saliva as a useful tool for evaluating upper mucosal antibody response to influenza.
    PLoS One. 2022;17:e0263419.
    PubMed     Abstract available

  511. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    PubMed     Abstract available

  512. FREUDENBERGER CATANZARO KC, Lahmers KK, Allen IC, Inzana TJ, et al
    Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.
    PLoS One. 2022;17:e0259807.
    PubMed     Abstract available

  513. GEORGE CE, Inbaraj LR, Rajukutty S, Joan RF, et al
    Seroprevalence of COVID-19 infection among vaccine naive population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
    PLoS One. 2022;17:e0265236.
    PubMed     Abstract available

  514. CHUKWU CA, Mahmood K, Elmakki S, Gorton J, et al
    Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
    PLoS One. 2022;17:e0265130.
    PubMed     Abstract available

  515. GREYLING T, Rossouw S
    Positive attitudes towards COVID-19 vaccines: A cross-country analysis.
    PLoS One. 2022;17:e0264994.
    PubMed     Abstract available

  516. TOLOSSA T, Wakuma B, Turi E, Mulisa D, et al
    Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey.
    PLoS One. 2022;17:e0265061.
    PubMed     Abstract available

  517. KUGELER KJ, Williamson J, Curns AT, Healy JM, et al
    Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021.
    PLoS One. 2022;17:e0264179.
    PubMed     Abstract available

  518. ORTIZ-PAREDES D, Varsaneux O, Worthington J, Park H, et al
    Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons.
    PLoS One. 2022;17:e0264145.
    PubMed     Abstract available

  519. TZOU PL, Tao K, Pond SLK, Shafer RW, et al
    Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons.
    PLoS One. 2022;17:e0261045.
    PubMed     Abstract available

  520. ROCHA FILHO TM, Mendes JFF, Murari TB, Nascimento Filho AS, et al
    Optimization of COVID-19 vaccination and the role of individuals with a high number of contacts: A model based approach.
    PLoS One. 2022;17:e0262433.
    PubMed     Abstract available

  521. HABIBZADEH F, Chumakov K, Sajadi MM, Yadollahie M, et al
    Use of oral polio vaccine and the incidence of COVID-19 in the world.
    PLoS One. 2022;17:e0265562.
    PubMed     Abstract available

  522. XIAO S, Nayak B, Samuel A, Paldurai A, et al
    Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain.
    PLoS One. 2022;17:e0265578.
    PubMed     Abstract available

  523. HAMILTON K, Hagger MS
    The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation.
    PLoS One. 2022;17:e0264784.
    PubMed     Abstract available

  524. BEG BM, Hussain T, Ahmad M, Areej S, et al
    Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.
    PLoS One. 2022;17:e0266028.
    PubMed     Abstract available

  525. REINHARDT B, Taylor R, Dawkins C, Banks T, et al
    The use of dried blood spot cards to assess serologic responses of individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster.
    PLoS One. 2022;17:e0265813.
    PubMed     Abstract available

  526. SAJID M, Marriam S, Mukhtar H, Sohail S, et al
    Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2.
    PLoS One. 2022;17:e0264700.
    PubMed     Abstract available

  527. ROY DN, Biswas M, Islam E, Azam MS, et al
    Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review.
    PLoS One. 2022;17:e0265496.
    PubMed     Abstract available

  528. DHAOUADI S, Kharroubi G, Cherif A, Cherif I, et al
    Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia.
    PLoS One. 2022;17:e0265390.
    PubMed     Abstract available

  529. SPRENGER R, Hackl D, Kossack N, Schiffner-Rohe J, et al
    Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    PLoS One. 2022;17:e0265433.
    PubMed     Abstract available

  530. PURSELL T, Spencer Clinton JL, Tan J, Peng R, et al
    Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.
    PLoS One. 2022;17:e0265424.
    PubMed     Abstract available

  531. HIMBERT S, Gastaldo IP, Ahmed R, Pomier KM, et al
    Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes.
    PLoS One. 2022;17:e0263671.
    PubMed     Abstract available

  532. HARTMANN W, Brunn ML, Stetter N, Gabriel G, et al
    Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in mice.
    PLoS One. 2022;17:e0266456.
    PubMed     Abstract available

  533. CHRISTODOULOU J, Fehrenbacher AE, Shaw EH, Vincent EM, et al
    COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV.
    PLoS One. 2022;17:e0266321.
    PubMed     Abstract available

  534. NEWMAN PA, Reid L, Tepjan S, Fantus S, et al
    COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review.
    PLoS One. 2022;17:e0266120.
    PubMed     Abstract available

  535. AL-DAHSHAN A, Selim N, Al-Kubaisi N, Mahfoud Z, et al
    Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar.
    PLoS One. 2022;17:e0265953.
    PubMed     Abstract available

  536. KREPS S, Kriner DL
    Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States.
    PLoS One. 2022;17:e0265011.
    PubMed     Abstract available

  537. THIRUMURTHY H, Milkman KL, Volpp KG, Buttenheim AM, et al
    Association between statewide financial incentive programs and COVID-19 vaccination rates.
    PLoS One. 2022;17:e0263425.
    PubMed     Abstract available

  538. NOURANI L, Abouie Mehrizi A, Zakeri S, Djadid ND, et al
    Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
    PLoS One. 2022;17:e0266067.
    PubMed     Abstract available

  539. HAJEK A, Konig HH
    Level and correlates of empathy and altruism during the Covid-19 pandemic. Evidence from a representative survey in Germany.
    PLoS One. 2022;17:e0265544.
    PubMed     Abstract available

  540. GRASO M
    The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations.
    PLoS One. 2022;17:e0266602.
    PubMed     Abstract available

  541. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    PubMed     Abstract available

  542. RAJA SM, Osman ME, Musa AO, Hussien AA, et al
    COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan.
    PLoS One. 2022;17:e0266670.
    PubMed     Abstract available

  543. FISKE A, Schonweitz F, Eichinger J, Zimmermann B, et al
    The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.
    PLoS One. 2022;17:e0266659.
    PubMed     Abstract available

  544. HASSOUNEH L, Dunsiger S
    The impact of mental distress on influenza vaccine coverage.
    PLoS One. 2022;17:e0266692.
    PubMed     Abstract available

  545. KAINE G, Wright V, Greenhalgh S
    Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand.
    PLoS One. 2022;17:e0266485.
    PubMed     Abstract available

  546. OCHWEDO KO, Onyango SA, Omondi CJ, Orondo PW, et al
    Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.
    PLoS One. 2022;17:e0266394.
    PubMed     Abstract available

  547. NAVAZI F, Yuan Y, Archer N
    The effect of the Ontario stay-at-home order on Covid-19 third wave infections including vaccination considerations: An interrupted time series analysis.
    PLoS One. 2022;17:e0265549.
    PubMed     Abstract available

  548. JENSEN UT, Ayers S, Koskan AM
    Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions.
    PLoS One. 2022;17:e0265736.
    PubMed     Abstract available

  549. REN Z, Nishimura M, Tjan LH, Furukawa K, et al
    Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak.
    PLoS One. 2022;17:e0266270.
    PubMed     Abstract available

  550. SHARMA R, Anand A
    The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines.
    PLoS One. 2022;17:e0266271.
    PubMed     Abstract available

  551. ALHATIM N, Al-Bashaireh AM, Alqudah O
    Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia.
    PLoS One. 2022;17:e0266440.
    PubMed     Abstract available

  552. KIHL P, Krych L, Deng L, Hansen LH, et al
    Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.
    PLoS One. 2022;17:e0266719.
    PubMed     Abstract available

  553. MEYERHARDT JA, Yue H, Nowak RP, Brais L, et al
    Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
    PLoS One. 2022;17:e0266791.
    PubMed     Abstract available

  554. RAHIMI BA, Ishaq N, Mudaser GM, Taylor WR, et al
    Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.
    PLoS One. 2022;17:e0265487.
    PubMed     Abstract available

  555. SEDEGAH M, Porter C, Hollingdale MR, Ganeshan H, et al
    CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
    PLoS One. 2022;17:e0266691.
    PubMed     Abstract available

  556. SARGENT RH, Laurie S, Moncada L, Weakland LF, et al
    Masks, money, and mandates: A national survey on efforts to increase COVID-19 vaccination intentions in the United States.
    PLoS One. 2022;17:e0267154.
    PubMed     Abstract available

  557. SAITO Y
    The role of vaccination in a model of asset pricing during a pandemic.
    PLoS One. 2022;17:e0266511.
    PubMed     Abstract available

  558. RABIL MJ, Tunc S, Bish DR, Bish EK, et al
    Benefits of integrated screening and vaccination for infection control.
    PLoS One. 2022;17:e0267388.
    PubMed     Abstract available

  559. MUNDAGOWA PT, Tozivepi SN, Chiyaka ET, Mukora-Mutseyekwa F, et al
    Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey.
    PLoS One. 2022;17:e0266724.
    PubMed     Abstract available

  560. BARMPOUNAKIS P, Demiris N, Kontoyiannis I, Pavlakis GN, et al
    Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece.
    PLoS One. 2022;17:e0263977.
    PubMed     Abstract available

  561. SHUKLA A, Welch K, Villa A
    Assessment of the willingness of dentists in the state of Indiana to administer vaccines.
    PLoS One. 2022;17:e0267167.
    PubMed     Abstract available

  562. LIN GSS, Lee HY, Leong JZ, Sulaiman MM, et al
    COVID-19 vaccination acceptance among dental students and dental practitioners: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267354.
    PubMed     Abstract available

  563. ABED ELHADI SHAHBARI N, Gesser-Edelsburg A, Davidovitch N, Brammli-Greenberg S, et al
    Risk perceptions regarding inclusion of seasonal influenza vaccinations in the school immunization program in Israel: Arab vs. Jewish mothers.
    PLoS One. 2022;17:e0267279.
    PubMed     Abstract available

  564. CHAM J, Pandey AC, New J, Huynh T, et al
    6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    PLoS One. 2022;17:e0266781.
    PubMed     Abstract available

  565. GAULTIER GN, Nix EB, Thorgrimson J, Boreham D, et al
    Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.
    PLoS One. 2022;17:e0267051.
    PubMed     Abstract available

  566. ANASTASSOPOULOU C, Antoni D, Manoussopoulos Y, Stefanou P, et al
    Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods.
    PLoS One. 2022;17:e0266958.
    PubMed     Abstract available

  567. JIAMSIRI S, Rhee C, Ahn HS, Poudyal N, et al
    A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand.
    PLoS One. 2022;17:e0267294.
    PubMed     Abstract available

  568. BUCZEL M, Szyszka PD, Siwiak A, Szpitalak M, et al
    Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
    PLoS One. 2022;17:e0267463.
    PubMed     Abstract available

  569. RIGHOLT CH, Willows K, Kliewer EV, Mahmud SM, et al
    Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    PLoS One. 2022;17:e0267646.
    PubMed     Abstract available

  570. WIGGEN TD, Bohn B, Ulrich AK, Stovitz SD, et al
    SARS-CoV-2 seroprevalence among healthcare workers.
    PLoS One. 2022;17:e0266410.
    PubMed     Abstract available

  571. RICHARDSON JR, Gotz R, Mayr V, Lohse MJ, et al
    SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
    PLoS One. 2022;17:e0266701.
    PubMed     Abstract available

  572. CHANSAENROJ J, Yorsaeng R, Puenpa J, Wanlapakorn N, et al
    Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    PLoS One. 2022;17:e0267102.
    PubMed     Abstract available

  573. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    PubMed     Abstract available

  574. HONG H, Malfeld S, Smit S, Makhathini L, et al
    A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine.
    PLoS One. 2022;17:e0265870.
    PubMed     Abstract available

  575. ASSI S, Arafat B, Abbas I, Evans K, et al
    Evaluation of portable near-infrared spectroscopy for authentication of mRNA based COVID-19 vaccines.
    PLoS One. 2022;17:e0267214.
    PubMed     Abstract available

  576. STOCKLI S, Spalti AK, Phillips J, Stoeckel F, et al
    Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment.
    PLoS One. 2022;17:e0266003.
    PubMed     Abstract available

  577. DONG L, Bogart LM, Gandhi P, Aboagye JB, et al
    A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake.
    PLoS One. 2022;17:e0268020.
    PubMed     Abstract available

  578. BICHER M, Rippinger C, Zechmeister M, Jahn B, et al
    An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply.
    PLoS One. 2022;17:e0265957.
    PubMed     Abstract available

  579. FLOREA A, Sy LS, Luo Y, Qian L, et al
    Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study.
    PLoS One. 2022;17:e0267824.
    PubMed     Abstract available

  580. STOTO MA, Schlageter S, Kraemer JD
    COVID-19 mortality in the United States: It's been two Americas from the start.
    PLoS One. 2022;17:e0265053.
    PubMed     Abstract available

  581. HONSKUS M, Okonji Z, Musilek M, Krizova P, et al
    Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993-2018.
    PLoS One. 2022;17:e0265066.
    PubMed     Abstract available

  582. OLU-ABIODUN O, Abiodun O, Okafor N
    COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.
    PLoS One. 2022;17:e0267691.
    PubMed     Abstract available

  583. FREUND O, Tau L, Weiss TE, Zornitzki L, et al
    Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era.
    PLoS One. 2022;17:e0268050.
    PubMed     Abstract available

  584. FARIA DE CARVALHO R, de Siqueira Penna Quintaes L, de Cassia de Souza Su T, Mitiko Kobayashi L, et al
    Short communication: Feasibility of dengue vaccine to infect different human cell lines: An alternative potency test using HEK293T cells.
    PLoS One. 2022;17:e0267653.
    PubMed     Abstract available

  585. HIJANO DR, Hoffman JM, Tang L, Schultz-Cherry SL, et al
    An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic.
    PLoS One. 2022;17:e0268237.
    PubMed     Abstract available

  586. OKUNLOLA OA, Oyeyemi OT
    Malaria transmission in Africa: Its relationship with yellow fever and measles.
    PLoS One. 2022;17:e0268080.
    PubMed     Abstract available

  587. MURUGESAN M, Mathews P, Paul H, Karthik R, et al
    Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India.
    PLoS One. 2022;17:e0268797.
    PubMed     Abstract available

  588. SSEKAMATTE T, Isunju JB, Mutyoba JN, Tetui M, et al
    Predictors of Hepatitis B screening and vaccination status of young psychoactive substance users in informal settlements in Kampala, Uganda.
    PLoS One. 2022;17:e0267953.
    PubMed     Abstract available

  589. DAZA-TORRES ML, Garcia YE, Schmidt AJ, Pollock BH, et al
    The impact of COVID-19 vaccination on California's return to normalcy.
    PLoS One. 2022;17:e0264195.
    PubMed     Abstract available

  590. OSUJI VC, Galante EM, Mischoulon D, Slaven JE, et al
    COVID-19 vaccine: A 2021 analysis of perceptions on vaccine safety and promise in a U.S. sample.
    PLoS One. 2022;17:e0268784.
    PubMed     Abstract available

  591. BONNER KE, Ssekyanzi H, Sicsic J, Mueller JE, et al
    What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.
    PLoS One. 2022;17:e0268063.
    PubMed     Abstract available

  592. WITUS LS, Larson E
    A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention.
    PLoS One. 2022;17:e0267580.
    PubMed     Abstract available

  593. GUZMAN-HOLST A, Luna-Casas G, Burguete Garcia A, Madrid-Marina V, et al
    Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study.
    PLoS One. 2022;17:e0268469.
    PubMed     Abstract available

  594. ACKAH M, Ameyaw L, Gazali Salifu M, Afi Asubonteng DP, et al
    COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268711.
    PubMed     Abstract available

  595. IWAMOTO M, Ukimura A, Ogawa T, Kawanishi F, et al
    Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.
    PLoS One. 2022;17:e0268529.
    PubMed     Abstract available

  596. EL DEEB O, Jalloul M
    Efficacy versus abundancy: Comparing vaccination schemes.
    PLoS One. 2022;17:e0267840.
    PubMed     Abstract available

  597. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    PubMed     Abstract available

  598. SEREDA AD, Kazakova AS, Dmitrenko VV, Kolbasov DV, et al
    Search for additional tests for immunobiological evaluation of the candidate vaccines against African swine fever.
    PLoS One. 2022;17:e0265819.
    PubMed     Abstract available

    It's Time to be disgusting about COVID-19: Effect of disgust priming on COVID-19 public health compliance among liberals and conservatives.
    PLoS One. 2022;17:e0267735.
    PubMed     Abstract available

  600. BUTLER JZ, Carson M, Rios-Fetchko F, Vargas R, et al
    COVID-19 vaccination readiness among multiple racial and ethnic groups in the San Francisco Bay Area: A qualitative analysis.
    PLoS One. 2022;17:e0266397.
    PubMed     Abstract available

  601. ASRI A, Asri V, Renerte B, Follmi-Heusi F, et al
    Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.
    PLoS One. 2022;17:e0268775.
    PubMed     Abstract available

  602. AHETO JMK, Pannell O, Dotse-Gborgbortsi W, Trimner MK, et al
    Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria.
    PLoS One. 2022;17:e0269066.
    PubMed     Abstract available

  603. SPRENGHOLZ P, Henkel L, Betsch C
    Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in Germany.
    PLoS One. 2022;17:e0268911.
    PubMed     Abstract available

  604. SILVA EKVB, Bomfim CG, Barbosa AP, Noda P, et al
    Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.
    PLoS One. 2022;17:e0268434.
    PubMed     Abstract available

  605. RAQIB R, Sarker P, Akhtar E, Nurul Huda TM, et al
    Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    PLoS One. 2022;17:e0268093.
    PubMed     Abstract available

  606. NG JWJ, Vaithilingam S, Nair M, Hwang LA, et al
    Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
    PLoS One. 2022;17:e0268926.
    PubMed     Abstract available

  607. NISHIMURA M, Sugawa S, Ota S, Suematsu E, et al
    Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
    PLoS One. 2022;17:e0267566.
    PubMed     Abstract available

  608. AGHAMIR SMK, Khatami F, Farrokhpour H, Oliveira Reis L, et al
    Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis.
    PLoS One. 2022;17:e0267934.
    PubMed     Abstract available

  609. GEBRETNSAE H, Hadgu T, Ayele B, Gebre-Egziabher E, et al
    Knowledge of vaccine handlers and status of cold chain and vaccine management in primary health care facilities of Tigray region, Northern Ethiopia: Institutional based cross-sectional study.
    PLoS One. 2022;17:e0269183.
    PubMed     Abstract available

  610. ROGERS BG, Tao J, Almonte A, Toma E, et al
    Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island.
    PLoS One. 2022;17:e0268587.
    PubMed     Abstract available

  611. PILTCH-LOEB R, Silver DR, Kim Y, Norris H, et al
    Determinants of the COVID-19 vaccine hesitancy spectrum.
    PLoS One. 2022;17:e0267734.
    PubMed     Abstract available

  612. AHIAKPA JK, Cosmas NT, Anyiam FE, Enalume KO, et al
    COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans.
    PLoS One. 2022;17:e0268230.
    PubMed     Abstract available

  613. JOSHI A, Surapaneni KM, Kaur M, Bhatt A, et al
    A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    PLoS One. 2022;17:e0269299.
    PubMed     Abstract available

  614. PATRICK L, Bakeera-Kitaka S, Rujumba J, Malande OO, et al
    Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
    PLoS One. 2022;17:e0269655.
    PubMed     Abstract available

  615. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available

  616. ERCHICK DJ, Gupta M, Blunt M, Bansal A, et al
    Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.
    PLoS One. 2022;17:e0269606.
    PubMed     Abstract available

  617. KHAIRKHAH N, Bolhassani A, Agi E, Namvar A, et al
    Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen.
    PLoS One. 2022;17:e0268251.
    PubMed     Abstract available

  618. BITZENHOFER M, Suter-Riniker F, Moor MB, Sidler D, et al
    Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
    PLoS One. 2022;17:e0268780.
    PubMed     Abstract available

  619. DARKWA S, de Wildt G, Dalaba M, Vidzro E, et al
    "I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana.
    PLoS One. 2022;17:e0268009.
    PubMed     Abstract available

  620. VILLANUEVA P, Wadia U, Crawford NW, Messina NL, et al
    The safety of co-administration of Bacille Calmette-Guerin (BCG) and influenza vaccines.
    PLoS One. 2022;17:e0268042.
    PubMed     Abstract available

  621. MOSE A, Wasie A, Shitu S, Haile K, et al
    Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269273.
    PubMed     Abstract available

  622. DE ANDRADE PEREIRA SILVA M, Ribeiro HF, Oliveira RR, Pelloso FC, et al
    Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study.
    PLoS One. 2022;17:e0269091.
    PubMed     Abstract available

  623. BOHN-GOLDBAUM E, Owen KB, Lee VYJ, Booy R, et al
    Physical activity and acute exercise benefit influenza vaccination response: A systematic review with individual participant data meta-analysis.
    PLoS One. 2022;17:e0268625.
    PubMed     Abstract available

  624. GU M, Taylor B, Pollack HA, Schneider JA, et al
    A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US.
    PLoS One. 2022;17:e0269320.
    PubMed     Abstract available

  625. RANI MDM, Mohamed NA, Solehan HM, Ithnin M, et al
    Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach.
    PLoS One. 2022;17:e0269059.
    PubMed     Abstract available

  626. PAPANEOPHYTOU C, Nicolaou A, Pieri M, Nicolaidou V, et al
    Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.
    PLoS One. 2022;17:e0269885.
    PubMed     Abstract available

  627. RANGELOVA V, Raycheva R, Sariyan S, Kevorkyan A, et al
    Reporting adverse events of COVID-19 vaccines: The case of Bulgaria.
    PLoS One. 2022;17:e0269727.
    PubMed     Abstract available

  628. KOBASHI Y, Shimazu Y, Kawamura T, Nishikawa Y, et al
    Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
    PLoS One. 2022;17:e0269917.
    PubMed     Abstract available

  629. PAWASKAR M, Fergie J, Harley C, Samant S, et al
    Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.
    PLoS One. 2022;17:e0269916.
    PubMed     Abstract available

  630. MA Y, Zhao Y, Chen R, Sun W, et al
    Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.
    PLoS One. 2022;17:e0269153.
    PubMed     Abstract available

  631. DESALEGN M, Garoma G, Tamrat H, Desta A, et al
    The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    PLoS One. 2022;17:e0265140.
    PubMed     Abstract available

  632. CERVANTES-LUEVANO K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, et al
    Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
    PLoS One. 2022;17:e0269032.
    PubMed     Abstract available

  633. SIEWCHAISAKUL P, Sarakarn P, Nanthanangkul S, Longkul J, et al
    Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among village health volunteers in Thailand.
    PLoS One. 2022;17:e0270023.
    PubMed     Abstract available

  634. MOONEY J, Price J, Bain C, Bawa JT, et al
    Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.
    PLoS One. 2022;17:e0270369.
    PubMed     Abstract available

  635. LANIER HD, Diaz MI, Saleh SN, Lehmann CU, et al
    Analyzing COVID-19 disinformation on Twitter using the hashtags #scamdemic and #plandemic: Retrospective study.
    PLoS One. 2022;17:e0268409.
    PubMed     Abstract available

  636. BACURAU AGM, Sato APS, Francisco PMSB
    Correction: Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2022;17:e0270443.
    PubMed     Abstract available

  637. TAKEUCHI M, Esaki A, Higa Y, Nakazono A, et al
    Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?
    PLoS One. 2022;17:e0263486.
    PubMed     Abstract available

  638. ACHENBACH CJ, Caputo M, Hawkins C, Balmert LC, et al
    Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.
    PLoS One. 2022;17:e0270060.
    PubMed     Abstract available

  639. ABAY ES, Belew MD, Ketsela BS, Mengistu EE, et al
    Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0269923.
    PubMed     Abstract available

  640. AWUNI JA, Ayamga M, Dagunga G
    Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?
    PLoS One. 2022;17:e0270742.
    PubMed     Abstract available

  641. SAAD E, Sadiq S, Jamil R, Rustam F, et al
    Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
    PLoS One. 2022;17:e0270327.
    PubMed     Abstract available

  642. BURGER MN, Mayer M, Steimanis I
    Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.
    PLoS One. 2022;17:e0270666.
    PubMed     Abstract available

  643. RAHMAN MM, Chisty MA, Alam MA, Sakib MS, et al
    Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.
    PLoS One. 2022;17:e0270684.
    PubMed     Abstract available

  644. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    PubMed     Abstract available

  645. FERGIE J, Pawaskar M, Veeranki P, Samant S, et al
    Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
    PLoS One. 2022;17:e0269596.
    PubMed     Abstract available

  646. ATSAWASUWAN P, Del Campo DM, Del Campo LM, Viana G, et al
    Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.
    PLoS One. 2022;17:e0270311.
    PubMed     Abstract available

  647. PRAKASH A, Jeyakumar Nathan R, Kini S, Victor V, et al
    Message framing and COVID-19 vaccine acceptance among millennials in South India.
    PLoS One. 2022;17:e0269487.
    PubMed     Abstract available

  648. OKAI GA, Abekah-Nkrumah G
    The level and determinants of COVID-19 vaccine acceptance in Ghana.
    PLoS One. 2022;17:e0270768.
    PubMed     Abstract available

  649. MAGEE L, Knights F, Mckechnie DGJ, Al-Bedaery R, et al
    Facilitators and barriers to COVID-19 vaccination uptake among ethnic minorities: A qualitative study in primary care.
    PLoS One. 2022;17:e0270504.
    PubMed     Abstract available

  650. JAFAR A, Dambul R, Dollah R, Sakke N, et al
    COVID-19 vaccine hesitancy in Malaysia: Exploring factors and identifying highly vulnerable groups.
    PLoS One. 2022;17:e0270868.
    PubMed     Abstract available

  651. FIERRO A, Romano S, Liccardo A
    Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.
    PLoS One. 2022;17:e0265159.
    PubMed     Abstract available

  652. BEREC L, Smid M, Pribylova L, Majek O, et al
    Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
    PLoS One. 2022;17:e0270801.
    PubMed     Abstract available

  653. BAIDEN F, Fleck S, Leigh B, Ayieko P, et al
    Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.
    PLoS One. 2022;17:e0270968.
    PubMed     Abstract available

  654. WANG J, Xu Z, Gao Q
    Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020.
    PLoS One. 2022;17:e0270630.
    PubMed     Abstract available

  655. ABO SHAMA NM, Mahmoud SH, Bagato O, AbdElsalam ET, et al
    Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
    PLoS One. 2022;17:e0269321.
    PubMed     Abstract available

  656. DROPKIN G
    Variation in COVID-19 booster uptake in England: An ecological study.
    PLoS One. 2022;17:e0270624.
    PubMed     Abstract available

  657. KUMAR CK, Balasubramanian R, Ongarello S, Carmona S, et al
    SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations.
    PLoS One. 2022;17:e0271103.
    PubMed     Abstract available

  658. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    PubMed     Abstract available

  659. TEGEGNE MD, Girma S, Mengistu S, Mesfin T, et al
    Willingness to receive COVID-19 vaccine and associated factors among adult chronic patients. A cross-sectional study in Northwest Ethiopia.
    PLoS One. 2022;17:e0269942.
    PubMed     Abstract available

  660. KONISHI T
    Mutations in SARS-CoV-2 are on the increase against the acquired immunity.
    PLoS One. 2022;17:e0271305.
    PubMed     Abstract available

  661. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    PubMed     Abstract available

  662. SEREDA AD, Kazakova AS, Namsrayn SG, Vlasov ME, et al
    The attenuated ASFV strains MK-200 and FK-32/135 as possible models for investigation of protective immunity by ASFV infection.
    PLoS One. 2022;17:e0270641.
    PubMed     Abstract available

  663. GUJJULA KR, Gong J, Segundo B, Ntaimo L, et al
    COVID-19 vaccination policies under uncertain transmission characteristics using stochastic programming.
    PLoS One. 2022;17:e0270524.
    PubMed     Abstract available

  664. LIU B, Zhang M, Li X, Liu L, et al
    Influence of epidemic situation on COVID-19 vaccination between urban and rural residents in China-Vietnam border area: A cross-sectional survey.
    PLoS One. 2022;17:e0270345.
    PubMed     Abstract available

  665. HERMAN B, Wong MC, Viwattanakulvanid P
    Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study.
    PLoS One. 2022;17:e0271385.
    PubMed     Abstract available

  666. SIEGERS KE, van Herwaarden AE, de Waard JH, Del Nogal B, et al
    The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children.
    PLoS One. 2022;17:e0270736.
    PubMed     Abstract available

  667. HANSON CK, Liu K
    Think about your friends and family: The disparate impacts of relationship-centered messages on privacy concerns, protective health behavior, and vaccination against Covid-19.
    PLoS One. 2022;17:e0270279.
    PubMed     Abstract available

  668. JUNGE M, Li S, Samaranayake S, Zalesak M, et al
    Safe reopening of university campuses is possible with COVID-19 vaccination.
    PLoS One. 2022;17:e0270106.
    PubMed     Abstract available

  669. ZHANG A, Li D, Song C, Jing H, et al
    Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck.
    PLoS One. 2022;17:e0271746.
    PubMed     Abstract available

  670. ABUHAMMAD S, Khabour OF, Alzoubi KH, Hamaideh S, et al
    The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan.
    PLoS One. 2022;17:e0271625.
    PubMed     Abstract available

  671. FATIMA S, Zafar A, Afzal H, Ejaz T, et al
    COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?
    PLoS One. 2022;17:e0270485.
    PubMed     Abstract available

  672. ABD EL FADEEL MR, Soliman EM, Allam AM, ElKersh MF, et al
    Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin.
    PLoS One. 2022;17:e0269031.
    PubMed     Abstract available

  673. TRAJMAN A, Lachapelle-Chisholm S, Zikos T, Werneck GL, et al
    Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis.
    PLoS One. 2022;17:e0265414.
    PubMed     Abstract available

  674. KADYROVA I, Yegorov S, Negmetzhanov B, Kolesnikova Y, et al
    High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination.
    PLoS One. 2022;17:e0272008.
    PubMed     Abstract available

  675. HWANG J, Su MH, Jiang X, Lian R, et al
    Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy.
    PLoS One. 2022;17:e0271394.
    PubMed     Abstract available

  676. GOTO T, Tani N, Ikematsu H, Gondo K, et al
    Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
    PLoS One. 2022;17:e0272056.
    PubMed     Abstract available

  677. KHOKHAR F, Pickard D, Dyson Z, Iqbal J, et al
    Multiplex PCR assay to detect high risk lineages of Salmonella Typhi and Paratyphi A.
    PLoS One. 2022;17:e0267805.
    PubMed     Abstract available

  678. AL-OBAYDI S, Hennrikus E, Mohammad N, Lehman EB, et al
    Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    PLoS One. 2022;17:e0272691.
    PubMed     Abstract available

  679. THORPE A, Fagerlin A, Butler J, Stevens V, et al
    Communicating about COVID-19 vaccine development and safety.
    PLoS One. 2022;17:e0272426.
    PubMed     Abstract available

  680. FACCIN M, Gargiulo F, Atlani-Duault L, Ward JK, et al
    Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic.
    PLoS One. 2022;17:e0271157.
    PubMed     Abstract available

  681. KAN Y, Asada M, Uesawa Y
    Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    PLoS One. 2022;17:e0269268.
    PubMed     Abstract available

  682. SUMALI B, Mitsukura Y, Nishimura T
    Contactless continuous heart rate monitoring system using ballistocardiography.
    PLoS One. 2022;17:e0272072.
    PubMed     Abstract available

    Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19.
    PLoS One. 2022;17:e0271446.
    PubMed     Abstract available

  684. LEE HW, Leng CH, Chan TC
    Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.
    PLoS One. 2022;17:e0270349.
    PubMed     Abstract available

  685. NAKAMANYA S, Kawuma R, Kibuuka D, Kusemererwa S, et al
    Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda.
    PLoS One. 2022;17:e0271104.
    PubMed     Abstract available

  686. SABZIAN-MOLAEI F, Nasiri Khalili MA, Sabzian-Molaei M, Shahsavarani H, et al
    Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection.
    PLoS One. 2022;17:e0268156.
    PubMed     Abstract available

  687. CHEN J, Chou SY, Yu TH, Rizqi ZU, et al
    System dynamics analysis on the effectiveness of vaccination and social mobilization policies for COVID-19 in the United States.
    PLoS One. 2022;17:e0268443.
    PubMed     Abstract available

  688. SHUI X, Wang F, Li L, Liang Q, et al
    COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273112.
    PubMed     Abstract available

  689. HUIBERTS A, van Cleef B, Tjon-A-Tsien A, Dijkstra F, et al
    Influenza vaccination of school teachers: A scoping review and an impact estimation.
    PLoS One. 2022;17:e0272332.
    PubMed     Abstract available

  690. RAYAMAJHI S, Rafi MA, Tripathi N, Dongol AS, et al
    Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    PLoS One. 2022;17:e0272729.
    PubMed     Abstract available

  691. MEGHANI A, Agarwal S, Zapf AJ, Edwards JG, et al
    Schooling amidst a pandemic in the United States: Parents' perceptions about reopening schools and anticipated challenges during COVID-19.
    PLoS One. 2022;17:e0268427.
    PubMed     Abstract available

  692. NKA AD, Ka'e AC, Bouba Y, Ngoufack Jagni Semengue E, et al
    Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0272839.
    PubMed     Abstract available

  693. ALSAGABY SA, Alharbi NK, Alhumaydhi FA, Alsubaie F, et al
    Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination.
    PLoS One. 2022;17:e0272869.
    PubMed     Abstract available

  694. AEMRO A, Fentie B, Wassie M
    Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia.
    PLoS One. 2022;17:e0272570.
    PubMed     Abstract available

  695. SADEGHI K, Poorolajal J, Doosti-Irani A
    Prevalence of modifiable risk factors of tuberculosis and their population attributable fraction in Iran: A cross-sectional study.
    PLoS One. 2022;17:e0271511.
    PubMed     Abstract available

  696. SALVI N, Itta KC, Lachyan A, Hasan AZ, et al
    Experiences of sharing results of community based serosurvey with participants in a district of Maharashtra, India.
    PLoS One. 2022;17:e0271920.
    PubMed     Abstract available

  697. RAYHAN MRI, Liza JM, Rahman MM
    Assessment of COVID-19 vaccination-related medical waste management practices in Bangladesh.
    PLoS One. 2022;17:e0273053.
    PubMed     Abstract available

  698. AFRIFA-ANANE GF, Larbi RT, Addo B, Agyekum MW, et al
    Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study.
    PLoS One. 2022;17:e0272876.
    PubMed     Abstract available

  699. HUSAIN F, Powys VR, White E, Jones R, et al
    COVID-19 vaccination uptake in 441 socially and ethnically diverse pregnant women.
    PLoS One. 2022;17:e0271834.
    PubMed     Abstract available

  700. LEONE V, Meisinger C, Temizel S, Kling E, et al
    Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
    PLoS One. 2022;17:e0272874.
    PubMed     Abstract available

  701. YAKUM MN, Funwie AD, Ajong AB, Tsafack M, et al
    Factors associated with routine vaccination card retention among children aged 0-59 months in Yaounde-Cameroon: A cross-sectional survey.
    PLoS One. 2022;17:e0273515.
    PubMed     Abstract available

  702. ZHANG M, Tian J, Li H, Cang M, et al
    The comparative genomic analysis provides insights into the phylogeny and virulence of tick-borne encephalitis virus vaccine strain Senzhang.
    PLoS One. 2022;17:e0273565.
    PubMed     Abstract available

  703. APIWATTANAKUL M, Suanprasert N, Rojana-Udomsart A, Termglinchan T, et al
    Good recovery of immunization stress-related responses presenting as a cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations.
    PLoS One. 2022;17:e0266118.
    PubMed     Abstract available

  704. KUMAR N, Sulaiman SAS, Hashmi FK, Qureshi A, et al
    Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination.
    PLoS One. 2022;17:e0270900.
    PubMed     Abstract available

  705. LUBEYA MK, Mwanahamuntu M, Chibwesha C, Mukosha M, et al
    Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2022;17:e0267617.
    PubMed     Abstract available

  706. SEN SR, Sanders EC, Santos AM, Bhuvan K, et al
    Evidence for deleterious effects of immunological history in SARS-CoV-2.
    PLoS One. 2022;17:e0272163.
    PubMed     Abstract available

  707. NUZHATH T, Hotez PJ, Damania A, Liu PS, et al
    Creation of a Global Vaccine Risk Index.
    PLoS One. 2022;17:e0272784.
    PubMed     Abstract available

  708. HERRMANN-WERNER A, Festl-Wietek T, Gille C, Zipfel S, et al
    Medical student attitudes on vaccination relevance: A mixed-method study.
    PLoS One. 2022;17:e0273529.
    PubMed     Abstract available

  709. OTENG AGYEMAN F, Ma Z, Li M, Kwasi Sampene A, et al
    Relevance of COVID-19 vaccine on the tourism industry: Evidence from China.
    PLoS One. 2022;17:e0269200.
    PubMed     Abstract available

  710. ASRATIE MH, Kassie BA, Belay DG, Endalew M, et al
    Perception of risk regarding the use of COVID-19 vaccine among pregnant women in Motta town and Hulet Eji Enese district, northwest Ethiopia.
    PLoS One. 2022;17:e0269591.
    PubMed     Abstract available

  711. DARWISH I, Harrison LB, Passos-Castilho AM, Labbe AC, et al
    In-hospital outcomes of SARS-CoV-2-infected health care workers in the COVID-19 pandemic first wave, Quebec, Canada.
    PLoS One. 2022;17:e0272953.
    PubMed     Abstract available

  712. HOSSAIN MS, Islam MS, Pardhan S, Banik R, et al
    Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study.
    PLoS One. 2022;17:e0269944.
    PubMed     Abstract available

  713. CHOQUE-GUEVARA R, Poma-Acevedo A, Montesinos-Millan R, Rios-Matos D, et al
    Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models.
    PLoS One. 2022;17:e0269823.
    PubMed     Abstract available

  714. ROJAS CONVERSO T, Goulart C, Rodriguez D, Guerra MES, et al
    Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.
    PLoS One. 2022;17:e0273017.
    PubMed     Abstract available

  715. STERNJAKOB-MARTHALER A, Berko-Gottel B, Rissland J, Schope J, et al
    Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    PLoS One. 2022;17:e0273332.
    PubMed     Abstract available

  716. BURATTO A, Muttoni M, Wrzaczek S, Freiberger M, et al
    Should the COVID-19 lockdown be relaxed or intensified in case a vaccine becomes available?
    PLoS One. 2022;17:e0273557.
    PubMed     Abstract available

  717. JIANG F, Zhao Y, Bai J, Yang X, et al
    Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis.
    PLoS One. 2022;17:e0273285.
    PubMed     Abstract available

  718. WASSERBAUER M, Hlava S, Trojanek M, Stovicek J, et al
    Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
    PLoS One. 2022;17:e0273612.
    PubMed     Abstract available

  719. LEE KW, Gew LT, Siau CS, Peh SC, et al
    COVID-19 vaccine hesitancy and its associated factors in Malaysia.
    PLoS One. 2022;17:e0266925.
    PubMed     Abstract available

  720. WAGGLE KD, Griffith MP, Zhu L, Cooper VS, et al
    Genomic characterization of SARS-CoV-2 from vaccine breakthrough cases in Allegheny County, Pennsylvania.
    PLoS One. 2022;17:e0272954.
    PubMed     Abstract available

  721. BEHMARD E, Abdulabbas HT, Abdalkareem Jasim S, Najafipour S, et al
    Design of a novel multi-epitope vaccine candidate against hepatitis C virus using structural and nonstructural proteins: An immunoinformatics approach.
    PLoS One. 2022;17:e0272582.
    PubMed     Abstract available

  722. NASIRI O, Hajihassani M, Noori Goodarzi N, Fereshteh S, et al
    Reverse vaccinology approach to identify novel and immunogenic targets against Porphyromonas gingivalis: An in silico study.
    PLoS One. 2022;17:e0273770.
    PubMed     Abstract available

  723. SANNEH B, Sanneh S, Lareef-Jah S, Darboe B, et al
    Practice of preventive measures and vaccine hesitance for COVID 19 among households in The Gambia, 2021: Study protocol.
    PLoS One. 2022;17:e0270304.
    PubMed     Abstract available

  724. KYEI-ARTHUR F, Kyei-Gyamfi S, Agyekum MW, Afrifa-Anane GF, et al
    Parents' and guardians' acceptability of COVID-19 vaccination for children in Ghana: An online survey.
    PLoS One. 2022;17:e0272801.
    PubMed     Abstract available

  725. SCHNEPF J
    Does perceived scarcity of COVID-19 vaccines increase vaccination willingness? Results of an experimental study with German respondents in times of a national vaccine shortage.
    PLoS One. 2022;17:e0273441.
    PubMed     Abstract available

  726. SAELEE C, Hanthamrongwit J, Soe PT, Khaenam P, et al
    Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
    PLoS One. 2022;17:e0273517.
    PubMed     Abstract available

  727. HOANG PT, Luong QXT, Cho S, Lee Y, et al
    Enhancing neutralizing activity against influenza H1N1/PR8 by engineering a single-domain VL-M2 specific into a bivalent form.
    PLoS One. 2022;17:e0273934.
    PubMed     Abstract available

  728. GUNAWARDHANA N, Baecher K, Boutwell A, Pekwarake S, et al
    COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa.
    PLoS One. 2022;17:e0274541.
    PubMed     Abstract available

  729. MACHADO A, Kislaya I, Rodrigues AP, Sequeira D, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged >/=65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021
    PLoS One. 2022;17:e0274008.
    PubMed     Abstract available

  730. REBITSCHEK FG, Ellermann C, Jenny MA, Siegel NA, et al
    Fact boxes that inform individual decisions may contribute to a more positive evaluation of COVID-19 vaccinations at the population level.
    PLoS One. 2022;17:e0274186.
    PubMed     Abstract available

  731. DESANTIS SM, Leon-Novelo LG, Swartz MD, Yaseen AS, et al
    Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region.
    PLoS One. 2022;17:e0273694.
    PubMed     Abstract available

  732. SEMENZATO L, Botton J, Baricault B, Deloumeaux J, et al
    Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    PLoS One. 2022;17:e0274309.
    PubMed     Abstract available

  733. VALDES-DONOSO P, Jarvis LS
    Combining epidemiology and economics to assess control of a viral endemic animal disease: Porcine Reproductive and Respiratory Syndrome (PRRS).
    PLoS One. 2022;17:e0274382.
    PubMed     Abstract available

  734. GOGOI M, Wobi F, Qureshi I, Al-Oraibi A, et al
    "The vaccination is positive; I don't think it's the panacea": A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom.
    PLoS One. 2022;17:e0273687.
    PubMed     Abstract available

  735. ISMAIL N, Tavoschi L, Moazen B, Rosello A, et al
    COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review.
    PLoS One. 2022;17:e0267070.
    PubMed     Abstract available

  736. FULLER A, Hancox J, Vedhara K, Card T, et al
    Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.
    PLoS One. 2022;17:e0267769.
    PubMed     Abstract available

  737. YANG IN, Lu CL, Tang HJ, Kuo YC, et al
    Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis.
    PLoS One. 2022;17:e0273676.
    PubMed     Abstract available

  738. HUHN G, Poorbaugh J, Zhang L, Beasley S, et al
    COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
    PLoS One. 2022;17:e0273323.
    PubMed     Abstract available

  739. MOON YJ, Cho KS, Jeong JY, Chung DY, et al
    Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations.
    PLoS One. 2022;17:e0273733.
    PubMed     Abstract available

  740. BENNETT NG, Bloom DE, Ferranna M
    Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption.
    PLoS One. 2022;17:e0274529.
    PubMed     Abstract available

  741. AGOSTI F, Toffolutti V, Cavalli N, Nivakoski S, et al
    Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries.
    PLoS One. 2022;17:e0273555.
    PubMed     Abstract available

  742. LIMAYE RJ, Balgobin K, Michel A, Schulz G, et al
    What message appeal and messenger are most persuasive for COVID-19 vaccine uptake: Results from a 5-country survey in India, Indonesia, Kenya, Nigeria, and Ukraine.
    PLoS One. 2022;17:e0274966.
    PubMed     Abstract available

  743. WU H, Xue M, Wu C, Lu Q, et al
    Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
    PLoS One. 2022;17:e0274421.
    PubMed     Abstract available

  744. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    PubMed     Abstract available

  745. FRAUCHES TS, Costa CAS, Rodrigues CDS, de Azevedo MCVM, et al
    COVID-19 cross-sectional study in Marica, Brazil: The impact of vaccination coverage on viral incidence.
    PLoS One. 2022;17:e0269011.
    PubMed     Abstract available

  746. CAPPELLI L, Cinelli P, Giusti F, Ferlenghi I, et al
    Self-assembling protein nanoparticles and virus like particles correctly display beta-barrel from meningococcal factor H-binding protein through genetic fusion.
    PLoS One. 2022;17:e0273322.
    PubMed     Abstract available

  747. HEFELE L, Lai J, Vilivong K, Bounkhoun T, et al
    Haemophilus influenzae serotype b seroprevalence in central Lao PDR before and after vaccine introduction.
    PLoS One. 2022;17:e0274558.
    PubMed     Abstract available

  748. SERETI I, Shaw-Saliba K, Dodd LE, Dewar RL, et al
    Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
    PLoS One. 2022;17:e0273914.
    PubMed     Abstract available

  749. GRAVAGNA K, Wolfson C, Sulis G, Buchan SA, et al
    Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging.
    PLoS One. 2022;17:e0275135.
    PubMed     Abstract available

  750. DE BOER J, Saade U, Granjon E, Trouillet-Assant S, et al
    A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects.
    PLoS One. 2022;17:e0274553.
    PubMed     Abstract available

  751. DAS P, Igoe M, Lenhart S, Luong L, et al
    Geographic disparities and determinants of COVID-19 incidence risk in the greater St. Louis Area, Missouri (United States).
    PLoS One. 2022;17:e0274899.
    PubMed     Abstract available

  752. AZAMI M, Nasirkandy MP, Esmaeili Gouvarchin Ghaleh H, Ranjbar R, et al
    COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272273.
    PubMed     Abstract available

  753. FULLER S, Kazemian S, Algara C, Simmons DJ, et al
    Assessing the effectiveness of COVID-19 vaccine lotteries: A cross-state synthetic control methods approach.
    PLoS One. 2022;17:e0274374.
    PubMed     Abstract available

  754. ABDUL AZIZ NI, Flanders S, Nungsari M
    Social expectations and government incentives in Malaysia's COVID-19 vaccine uptake.
    PLoS One. 2022;17:e0275010.
    PubMed     Abstract available

  755. ALLEN JD, Priebe Rocha L, Rose R, Hoch A, et al
    Intention to obtain a COVID-19 vaccine among Brazilian immigrant women in the U.S.
    PLoS One. 2022;17:e0274912.
    PubMed     Abstract available

  756. NICHOL B, Simonetti V, McCready J, Steen M, et al
    Barriers and facilitators to vaccination for COVID-19, pertussis, and influenza during pregnancy: Protocol for an umbrella review.
    PLoS One. 2022;17:e0275105.
    PubMed     Abstract available

  757. BETOUKE ONGWE ME, Mouwenda YD, Stam KA, Kremsner PG, et al
    Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.
    PLoS One. 2022;17:e0275013.
    PubMed     Abstract available

  758. YAKUBU AM, Aryee NA, Bonney EY, Kotey EN, et al
    Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017.
    PLoS One. 2022;17:e0271321.
    PubMed     Abstract available

  759. KALIFF M, Lillsunde Larsson G, Helenius G, Karlsson MG, et al
    Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Orebro, Sweden.
    PLoS One. 2022;17:e0274825.
    PubMed     Abstract available

  760. OKRUSZEK L, Piejka A, Banasik-Jemielniak N, Jemielniak D, et al
    Climate change, vaccines, GMO: The N400 effect as a marker of attitudes toward scientific issues.
    PLoS One. 2022;17:e0273346.
    PubMed     Abstract available

  761. BOCKSTAL V, Shukarev G, McLean C, Goldstein N, et al
    First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.
    PLoS One. 2022;17:e0274906.
    PubMed     Abstract available

  762. LUN P, Gao J, Tang B, Yu CC, et al
    A social ecological approach to identify the barriers and facilitators to COVID-19 vaccination acceptance: A scoping review.
    PLoS One. 2022;17:e0272642.
    PubMed     Abstract available

  763. NIEMINEN H, Hakulinen T, Puumalainen T, Siren P, et al
    Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics.
    PLoS One. 2022;17:e0270835.
    PubMed     Abstract available

  764. PAUDEL YR, Du C, MacDonald SE
    The influence of place on COVID-19 vaccine coverage in Alberta: A multilevel analysis.
    PLoS One. 2022;17:e0276160.
    PubMed     Abstract available

  765. KAPAR B, Buigut S, Rana F
    Winners and losers from Pfizer and Biontech's vaccine announcement: Evidence from S&P 500 (Sub)sector indices.
    PLoS One. 2022;17:e0275773.
    PubMed     Abstract available

  766. SULIS G, Rodrigue V, Wolfson C, McMillan JM, et al
    Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA).
    PLoS One. 2022;17:e0275923.
    PubMed     Abstract available

  767. WANG B, Wu L, Hong X, Han Y, et al
    Risk perception and subsidy policy-based voluntary vaccination driven by multiple information sources.
    PLoS One. 2022;17:e0276177.
    PubMed     Abstract available

  768. STREETER AJ, Rodgers LR, Masoli J, Lin NX, et al
    Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink.
    PLoS One. 2022;17:e0275642.
    PubMed     Abstract available

  769. JEEWANDARA C, Aberathna IS, Dayarathna S, Nimasha T, et al
    Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.
    PLoS One. 2022;17:e0274845.
    PubMed     Abstract available

  770. BIKAAKO W, Kabahango P, Mugabi K, Yawe A, et al
    Breaking institutional barriers to enhance women's participation in and benefit from the Peste des Petits Ruminants and Newcastle Disease vaccine value chains for Sembabule district of Uganda.
    PLoS One. 2022;17:e0270518.
    PubMed     Abstract available

  771. HANDAYANI S, Rias YA, Kurniasari MD, Agustin R, et al
    Relationship of spirituality, health engagement, health belief and attitudes toward acceptance and willingness to pay for a COVID-19 vaccine.
    PLoS One. 2022;17:e0274972.
    PubMed     Abstract available

  772. PETROVIC V, Ristic M, Milosavljevic B, Djilas M, et al
    Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
    PLoS One. 2022;17:e0274674.
    PubMed     Abstract available

  773. SALMON DA, Schuh HB, Sargent RH, Konja A, et al
    Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson & Johnson on vaccine hesitancy and acceptance among the unvaccinated population.
    PLoS One. 2022;17:e0274443.
    PubMed     Abstract available

  774. BAEK K, Maharjan S, Akauliya M, Thapa B, et al
    Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.
    PLoS One. 2022;17:e0275722.
    PubMed     Abstract available

  775. ALMONGY HM, Almetwally EM, Haj Ahmad H, H Al-Nefaie A, et al
    Modeling of COVID-19 vaccination rate using odd Lomax inverted Nadarajah-Haghighi distribution.
    PLoS One. 2022;17:e0276181.
    PubMed     Abstract available

  776. MARTINELLI M, Veltri GA
    Shared understandings of vaccine hesitancy: How perceived risk and trust in vaccination frame individuals' vaccine acceptance.
    PLoS One. 2022;17:e0276519.
    PubMed     Abstract available

  777. PARKER SJ, DeLaroche AM, Hill AB, Arora R, et al
    Influenza vaccination coverage among an urban pediatric asthma population: Implications for population health.
    PLoS One. 2022;17:e0269415.
    PubMed     Abstract available

  778. TADROUS M, Chung H, Men S, Chu C, et al
    Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study.
    PLoS One. 2022;17:e0273903.
    PubMed     Abstract available

  779. NAKAMURA A, Kotaki T, Nagai Y, Takazawa S, et al
    Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon.
    PLoS One. 2022;17:e0274829.
    PubMed     Abstract available

  780. AMIN MB, Roy N, Meem AE, Hossain E, et al
    Trends and determinants of taking tetanus toxoid vaccine among women during last pregnancy in Bangladesh: Country representative survey from 2006 to 2019.
    PLoS One. 2022;17:e0276417.
    PubMed     Abstract available

  781. DAHAL S, Pokhrel S, Mehta S, Karki S, et al
    Acceptance and hesitancy of COVID-19 vaccine among Nepalese population: A cross-sectional study.
    PLoS One. 2022;17:e0275922.
    PubMed     Abstract available

  782. NICKEL O, Rockstroh A, Wolf J, Landgraf S, et al
    Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2.
    PLoS One. 2022;17:e0263861.
    PubMed     Abstract available

  783. VANNI T, Thome BC, Sparrow E, Friede M, et al
    Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
    PLoS One. 2022;17:e0274943.
    PubMed     Abstract available

  784. ALMANSOUR A, Hussein SM, Felemban SG, Mahamid AW, et al
    Acceptance and hesitancy of parents to vaccinate children against coronavirus disease 2019 in Saudi Arabia.
    PLoS One. 2022;17:e0276183.
    PubMed     Abstract available

  785. SEDEGAH M, Porter C, Goguet E, Ganeshan H, et al
    Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.
    PLoS One. 2022;17:e0276241.
    PubMed     Abstract available

  786. VARGAS-HERRERA N, Fernandez-Navarro M, Cabezudo NE, Soto-Becerra P, et al
    Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru.
    PLoS One. 2022;17:e0268419.
    PubMed     Abstract available

  787. GAUTAM US, Asrican R, Sempowski GD
    Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system.
    PLoS One. 2022;17:e0276130.
    PubMed     Abstract available

  788. CONTRACTOR A, Shivaprakash S, Tiwari A, Setia MS, et al
    Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin (R)) in healthcare workers in Mumbai, India: A retrospective cohort analysis.
    PLoS One. 2022;17:e0276759.
    PubMed     Abstract available

  789. ARUFFO E, Yuan P, Tan Y, Gatov E, et al
    Community structured model for vaccine strategies to control COVID19 spread: A mathematical study.
    PLoS One. 2022;17:e0258648.
    PubMed     Abstract available

  790. TOBOLOWSKY FA, Waltenburg MA, Moritz ED, Haile M, et al
    Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020April 2021.
    PLoS One. 2022;17:e0275718.
    PubMed     Abstract available

  791. ENDERS AM, Uscinski J, Klofstad C, Stoler J, et al
    On the relationship between conspiracy theory beliefs, misinformation, and vaccine hesitancy.
    PLoS One. 2022;17:e0276082.
    PubMed     Abstract available

  792. CHERENACK EM, Salazar AS, Nogueira NF, Raccamarich P, et al
    Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age.
    PLoS One. 2022;17:e0276131.
    PubMed     Abstract available

  793. TARIMO EAM, Ambikile J, Munseri P, Bakari M, et al
    Personal experiences following acquiring HIV infection while volunteering in Phase I/II HIV vaccine trials: A qualitative study from Tanzania.
    PLoS One. 2022;17:e0276404.
    PubMed     Abstract available

  794. KIM YR, Choi YJ, Min Y
    A model of COVID-19 pandemic with vaccines and mutant viruses.
    PLoS One. 2022;17:e0275851.
    PubMed     Abstract available

  795. GOULART ROSA R, Spinardi J, Allen KE, Manfio J, et al
    BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.
    PLoS One. 2022;17:e0276384.
    PubMed     Abstract available

  796. GOMBE B, Streatfield C, Leal L, Opio S, et al
    Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.
    PLoS One. 2022;17:e0275927.
    PubMed     Abstract available

  797. FERNANDEZ-SUAREZ A, Jimenez Coronado R, Clavijo Aroca C, Navarro Martin E, et al
    New insights into antibody levels against SARS-CoV-2 for healthcare personnel vaccinated with tozinameran (Comirnaty).
    PLoS One. 2022;17:e0276968.
    PubMed     Abstract available

  798. ABDELHAMID MHM, Almsellati IA, Annajar BB, Abdulhamid AH, et al
    Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.
    PLoS One. 2022;17:e0276425.
    PubMed     Abstract available

  799. AYNALEM ZB, Bogale TW, Bantie GM, Ayalew AF, et al
    Factors associated with willingness to take COVID-19 vaccine among pregnant women at Gondar town, Northwest Ethiopia: A multicenter institution-based cross-sectional study.
    PLoS One. 2022;17:e0276763.
    PubMed     Abstract available

  800. GETACHEW D, Yosef T, Solomon N, Tesfaye M, et al
    Predictors of unwillingness to receive COVID -19 vaccines among Ethiopian Medical students.
    PLoS One. 2022;17:e0276857.
    PubMed     Abstract available

  801. GANESAN S, Acosta H, Brigolin C, Orange K, et al
    Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
    PLoS One. 2022;17:e0272594.
    PubMed     Abstract available

  802. KIM M, Kim JH, Jung YW, Seong SJ, et al
    Gynecologic problems and healthcare behavior by shift patterns in Korean nursing staff.
    PLoS One. 2022;17:e0276282.
    PubMed     Abstract available

  803. MAINA D, Omuse G, Ong'ete G, Mugaine P, et al
    Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
    PLoS One. 2022;17:e0267619.
    PubMed     Abstract available

  804. SAKAMOTO M, Ishizuka R, Ozawa C, Fukuda Y, et al
    Health information and COVID-19 vaccination: Beliefs and attitudes among Japanese university students.
    PLoS One. 2022;17:e0277435.
    PubMed     Abstract available

  805. OTHMAN B, Barakat M, Omar A, Al-Rawashdeh A, et al
    Evaluation of hepatitis B knowledge, practices, and beliefs among the Jordanian population: A cross-sectional study.
    PLoS One. 2022;17:e0277186.
    PubMed     Abstract available

  806. OLUSANYA OA, White B, Malik F, Hester KA, et al
    Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
    PLoS One. 2022;17:e0277748.
    PubMed     Abstract available

  807. DARWEESH O, Khatab N, Kheder R, Mohammed T, et al
    Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    PLoS One. 2022;17:e0274526.
    PubMed     Abstract available

  808. HOY C, Wood T, Moscoe E
    Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2022;17:e0277493.
    PubMed     Abstract available

    Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.
    PLoS One. 2022;17:e0277394.
    PubMed     Abstract available

  810. NEWCOMB K, Bilal S, Michael E
    Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures.
    PLoS One. 2022;17:e0277521.
    PubMed     Abstract available

  811. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    COVID-19 and Bangladeshi health professionals: Infection status, vaccination and its immediate health consequences.
    PLoS One. 2022;17:e0277022.
    PubMed     Abstract available

  812. PEREZ A, Johnson JK, Marquez DX, Keiser S, et al
    Factors related to COVID-19 vaccine intention in Latino communities.
    PLoS One. 2022;17:e0272627.
    PubMed     Abstract available

  813. LEE H, Noh EB, Kim JE, Oh J, et al
    Influencing factor of COVID-19 vaccination trust and hesitancy in Wonju city, South Korea.
    PLoS One. 2022;17:e0277016.
    PubMed     Abstract available

  814. KAREEM R, Sethi MR, Inayat S, Irfan M, et al
    The effect of COVID-19 vaccination on the menstrual pattern and mental health of the medical students: A mixed-methods study from a low and middle-income country.
    PLoS One. 2022;17:e0277288.
    PubMed     Abstract available

  815. BRACCI A, Nadini M, Aliapoulios M, McCoy D, et al
    Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic.
    PLoS One. 2022;17:e0275288.
    PubMed     Abstract available

  816. DABROWSKA-LEONIK N, Sawicka-Powierza J, Bernatowska E, Pac M, et al
    Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age.
    PLoS One. 2022;17:e0277473.
    PubMed     Abstract available

  817. TAMIRE M, Addissie A, Gizaw S, Abebe T, et al
    Household fuel use and its association with potential respiratory pathogens among healthy mothers and children in Ethiopia.
    PLoS One. 2022;17:e0277348.
    PubMed     Abstract available

  818. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    PubMed     Abstract available

  819. LIMANI F, Smith C, Wachepa R, Chafuwa H, et al
    Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study.
    PLoS One. 2022;17:e0277419.
    PubMed     Abstract available

  820. GALDIKIENE L, Jaraite J, Kajackaite A
    Trust and vaccination intentions: Evidence from Lithuania during the COVID-19 pandemic.
    PLoS One. 2022;17:e0278060.
    PubMed     Abstract available

  821. SARRIGEORGIOU I, Moschandreou D, Dimitriadis A, Tsinti G, et al
    Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.
    PLoS One. 2022;17:e0277827.
    PubMed     Abstract available

  822. LAKNEH EA, Mersha EA, Asresie MB, Belay HG, et al
    Knowledge, attitude, and uptake of human papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia.
    PLoS One. 2022;17:e0276465.
    PubMed     Abstract available

  823. SULAIMAN SK, Musa MS, Tsiga-Ahmed FI, Dayyab FM, et al
    A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs).
    PLoS One. 2022;17:e0278224.
    PubMed     Abstract available

  824. WINTERS M, Malik AA, Omer SB
    Attitudes towards Monkeypox vaccination and predictors of vaccination intentions among the US general public.
    PLoS One. 2022;17:e0278622.
    PubMed     Abstract available

  825. SAIGI-RUBIO F, Eguia H, Espelt A, Macip S, et al
    Hesitation about coronavirus vaccines in healthcare professionals and general population in Spain.
    PLoS One. 2022;17:e0277899.
    PubMed     Abstract available

  826. DELLA PIA A, Kim GYG, Ip A, Ahn J, et al
    Anti-spike antibody response to the COVID vaccine in lymphoma patients.
    PLoS One. 2022;17:e0266584.
    PubMed     Abstract available

  827. OCHE OM, Adamu H, Yahaya M, Illo HG, et al
    Perception and willingness to accept COVID-19 Vaccines: A cross-sectional survey of the general population of Sokoto State, Nigeria.
    PLoS One. 2022;17:e0278332.
    PubMed     Abstract available

  828. ABDULLAH M, Ahmad T, Kazmi T, Sultan F, et al
    Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan.
    PLoS One. 2022;17:e0274718.
    PubMed     Abstract available

  829. SRINIVASAN V, Weinstein SE, Bhimani A, Clemons NC, et al
    On variants and vaccines: The effectiveness of Covid-19 monoclonal antibody therapy during two distinct periods in the pandemic.
    PLoS One. 2022;17:e0278394.
    PubMed     Abstract available

  830. ALBANESE A, Fallucchi F, Verheyden B
    Can a supranational medicines agency restore trust after vaccine suspensions? The case of Vaxzevria.
    PLoS One. 2022;17:e0277554.
    PubMed     Abstract available

  831. TOPF KG, Sheppard M, Marx GE, Wiegand RE, et al
    Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5-17 Years during the Delta and Omicron Periods-United States, December 2020 to April 2022.
    PLoS One. 2022;17:e0276409.
    PubMed     Abstract available

  832. DAGNEW BAYE N, Agegnehu Teshome A, Agimas Ayenew A, Tilahun Mulu A, et al
    Attitude and level of COVID-19 vaccination and its determinants among patients with chronic disease visiting Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0278914.
    PubMed     Abstract available

  833. SEGNI MT, Demissie HF, Adem MK, Geleto AK, et al
    Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021.
    PLoS One. 2022;17:e0278334.
    PubMed     Abstract available

  834. LACY R, Puma J, Tubolino M, LaRocca D, et al
    Rural parents' attitudes and beliefs on the COVID-19 pediatric vaccine: An explanatory study.
    PLoS One. 2022;17:e0278611.
    PubMed     Abstract available

  835. BELAYACHI J, Obtel M, Mhayi A, Razine R, et al
    Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
    PLoS One. 2022;17:e0278546.
    PubMed     Abstract available

  836. WALLACE M, Collins JP, Moline H, Plumb ID, et al
    Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies.
    PLoS One. 2022;17:e0278624.
    PubMed     Abstract available

  837. VAN BERGEN I, Boger S, Beaudart C, Hiligsmann M, et al
    Beliefs regarding COVID-19 vaccinations of young adults in the United Kingdom: An interview study applying the Integrated Change Model.
    PLoS One. 2022;17:e0277109.
    PubMed     Abstract available

  838. DU L, Kou Z, Ma C, Tao X, et al
    Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines.
    PLoS One. 2022;17:e0278474.
    PubMed     Abstract available

  839. SUMPAICO-TANCHANCO LBC, Sy JCY, Dy ABC, Levantino M, et al
    The prevalence of SARS-CoV-2 antibodies within the community of a private tertiary university in the Philippines: A serial cross sectional study.
    PLoS One. 2022;17:e0268145.
    PubMed     Abstract available

  840. MUHINDO R, Okoboi S, Kiragga A, King R, et al
    COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda.
    PLoS One. 2022;17:e0278692.
    PubMed     Abstract available

  841. PETERSON CE, Dykens JA, Weine SM, Holt HK, et al
    Assessing the interrelationship between stigma, social influence, and cervical cancer prevention in an urban underserved setting: An exploratory study.
    PLoS One. 2022;17:e0278538.
    PubMed     Abstract available

  842. MALKIN J, Allen Scott L, Alberga Machado A, Teare G, et al
    Factors influencing human papillomavirus school-based immunization in Alberta: A mixed-methods study protocol.
    PLoS One. 2022;17:e0278472.
    PubMed     Abstract available

  843. AWASTHI S, Kohli N, Agarwal M, Pandey CM, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India.
    PLoS One. 2022;17:e0276911.
    PubMed     Abstract available

  844. FOX A, Choi Y, Lanthorn H, Croke K, et al
    Does highlighting COVID-19 disparities reduce or increase vaccine intentions? evidence from a survey experiment in a diverse sample in New York State prior to vaccine roll-out.
    PLoS One. 2022;17:e0277043.
    PubMed     Abstract available

  845. GEISSLER F, Hartmann F, Humphreys M, Kluver H, et al
    Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany.
    PLoS One. 2022;17:e0278337.
    PubMed     Abstract available

  846. OJEA QUINTANA I, Reimann R, Cheong M, Alfano M, et al
    Polarization and trust in the evolution of vaccine discourse on Twitter during COVID-19.
    PLoS One. 2022;17:e0277292.
    PubMed     Abstract available

  847. DEMONE J, Maltseva M, Nourimand M, Nasr-Sharif M, et al
    Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines.
    PLoS One. 2022;17:e0277668.
    PubMed     Abstract available

  848. LUNGTEN L, Tenzin T, Rinchen S, Chedup K, et al
    Assessment of the rabies education among middle secondary school students of southeastern Bhutan.
    PLoS One. 2022;17:e0276862.
    PubMed     Abstract available

  849. MAHARLOUEI N, Hosseinpour P, Erfani A, Shahriarirad R, et al
    Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.
    PLoS One. 2022;17:e0278967.
    PubMed     Abstract available

  850. NORMAN DA, Danchin M, Blyth CC, Palasanthiran P, et al
    Australian hospital paediatricians and nurses' perspectives and practices for influenza vaccine delivery in children with medical comorbidities.
    PLoS One. 2022;17:e0277874.
    PubMed     Abstract available

  851. SANDOVAL M, Nguyen DT, Huang HJ, Yi SG, et al
    COVID-19 mortality may be reduced among fully vaccinated solid organ transplant recipients.
    PLoS One. 2022;17:e0279222.
    PubMed     Abstract available

  852. ABDEL-MONEIM YAS, Alghamdi HY, Alrashed AM, Jawhari AM, et al
    Menstrual cycle changes: A cross-sectional study of Saudi females following SARS-CoV-2 infection.
    PLoS One. 2022;17:e0279408.
    PubMed     Abstract available

  853. ARJUN MC, Singh AK, Pal D, Das K, et al
    Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.
    PLoS One. 2022;17:e0278825.
    PubMed     Abstract available

  854. KHOO SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, et al
    Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
    PLoS One. 2022;17:e0278477.
    PubMed     Abstract available

  855. LEURS K, Goossens E, Christensen H, Mainil JG, et al
    Development of a duplex qPCR for the differentiation of a live attenuated Escherichia coli aroA mutant vaccine strain from field isolates in chickens.
    PLoS One. 2022;17:e0278949.
    PubMed     Abstract available

  856. ODONGO S, Okella H, Ndekezi C, Okee M, et al
    Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics.
    PLoS One. 2022;17:e0279428.
    PubMed     Abstract available

  857. Retraction: The anti-vaccination infodemic on social media: A behavioral analysis.
    PLoS One. 2022;17:e0279796.

  858. AWANDU SS, Ochieng Ochieng A, Onyango B, Magwanga RO, et al
    High seroprevalence of Immunoglobulin G (IgG) and IgM antibodies to SARS-CoV-2 in asymptomatic and symptomatic individuals amidst vaccination roll-out in western Kenya.
    PLoS One. 2022;17:e0272751.
    PubMed     Abstract available

  859. EISNECKER PS, Kroh M, Kuhne S
    The role of generalized trust in COVID-19 vaccine acceptance.
    PLoS One. 2022;17:e0278854.
    PubMed     Abstract available

  860. KNIPES AK, Summers A, Sklavounos AA, Lamanna J, et al
    Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.
    PLoS One. 2022;17:e0278749.
    PubMed     Abstract available

  861. SHEVTSOV A, Aushakhmetova Z, Amirgazin A, Khegay O, et al
    Whole genome sequence analysis of Neisseria meningitidis strains circulating in Kazakhstan, 2017-2018.
    PLoS One. 2022;17:e0279536.
    PubMed     Abstract available

  862. SMITH LE, Sherman SM, Sim J, Amlot R, et al
    Parents' intention to vaccinate their child for COVID-19: A mixed-methods study (CoVAccS-wave 3).
    PLoS One. 2022;17:e0279285.
    PubMed     Abstract available

  863. KHOLINA K, Harmon SHE, Graham JE
    An equitable vaccine delivery system: Lessons from the COVID-19 vaccine rollout in Canada.
    PLoS One. 2022;17:e0279929.
    PubMed     Abstract available

  864. LIU M, Zhao R, Ngai CSB
    Vaccines, media and politics: A corpus-assisted discourse study of press representations of the safety and efficacy of COVID-19 vaccines.
    PLoS One. 2022;17:e0279500.
    PubMed     Abstract available

  865. ODANI S, Koyama S, Katsumi Y, Miyashiro I, et al
    Attitudes toward COVID-19 vaccination during the state of emergency in Osaka, Japan.
    PLoS One. 2022;17:e0279481.
    PubMed     Abstract available

  866. CARLSON SJ, Tomkinson S, Blyth CC, Attwell K, et al
    COVID-19 vaccine knowledge, attitudes, and experiences of health care workers in Perth, Western Australia: A qualitative study.
    PLoS One. 2022;17:e0279557.
    PubMed     Abstract available

    January 2021
  867. KIM MH, Son NH, Park YS, Lee JH, et al
    Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects.
    PLoS One. 2021;16:e0258236.
    PubMed     Abstract available

  868. ROBERTSON CT, Bentele K, Meyerson B, Wood ASA, et al
    Effects of political versus expert messaging on vaccination intentions of Trump voters.
    PLoS One. 2021;16:e0257988.
    PubMed     Abstract available

  869. BACHELET T, Bourdenx JP, Martinez C, Mucha S, et al
    Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    PLoS One. 2021;16:e0257646.
    PubMed     Abstract available

  870. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan.
    PLoS One. 2021;16:e0250417.
    PubMed     Abstract available

  871. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    PubMed     Abstract available

  872. ZAKHOUR R, Tamim H, Faytrouni F, Khoury J, et al
    Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country.
    PLoS One. 2021;16:e0258258.
    PubMed     Abstract available

  873. WHELAN J, Marshall H, Sullivan TR
    Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.
    PLoS One. 2021;16:e0254330.
    PubMed     Abstract available

  874. NAVASCUES M, Budroni C, Guryanova Y
    Disease control as an optimization problem.
    PLoS One. 2021;16:e0257958.
    PubMed     Abstract available

  875. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available

  876. ROUBY SR, Safwat NM, Hussein KH, Abdel-Ra'ouf AM, et al
    Lumpy skin disease outbreaks in Egypt during 2017-2018 among sheeppox vaccinated cattle: Epidemiological, pathological, and molecular findings.
    PLoS One. 2021;16:e0258755.
    PubMed     Abstract available

  877. WIN TTZ, Campbell A, Magalhaes RJS, Oo KN, et al
    What drives small-scale farmers to vaccinate their multiple livestock species animals against common infectious diseases in Myanmar?
    PLoS One. 2021;16:e0258765.
    PubMed     Abstract available

  878. ALISHAQ M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, et al
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    PLoS One. 2021;16:e0258820.
    PubMed     Abstract available

  879. MALAMBA SS, Muyinda H, Ogwang DM, Katamba A, et al
    Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    PLoS One. 2021;16:e0251573.
    PubMed     Abstract available

  880. KURTZ SL, De Pascalis R, Meierovics AI, Elkins KL, et al
    Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
    PLoS One. 2021;16:e0249142.
    PubMed     Abstract available

  881. COHEN AA, Yang Z, Gnanapragasam PNP, Ou S, et al
    Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
    PLoS One. 2021;16:e0247963.
    PubMed     Abstract available

  882. BITAR AN, Zawiah M, Al-Ashwal FY, Kubas M, et al
    Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: A population-based survey in Yemen.
    PLoS One. 2021;16:e0248325.
    PubMed     Abstract available

  883. ARGOTE TIRONI P, Barham E, Zuckerman Daly S, Gerez JE, et al
    Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2021;16:e0259059.
    PubMed     Abstract available

  884. GAO X, Wang L, Zhang H, Zhu B, et al
    Transcriptome analysis and identification of genes associated with floral transition and fruit development in rabbiteye blueberry (Vaccinium ashei).
    PLoS One. 2021;16:e0259119.
    PubMed     Abstract available

  885. ELLIOTT T, Yehia BR, Winegar AL, Raja JK, et al
    Analysis of COVID-19 vaccine non-intent by essential vs non-essential worker, demographic, and socioeconomic status among 101,048 US adults.
    PLoS One. 2021;16:e0258540.
    PubMed     Abstract available

  886. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available

  887. LEONHARDT JM, Ridinger G, Rong Y, Talaei-Khoe A, et al
    Invincibility threatens vaccination intentions during a pandemic.
    PLoS One. 2021;16:e0258432.
    PubMed     Abstract available

  888. TARIQ MH, Bhatti R, Ali NF, Ashfaq UA, et al
    Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach.
    PLoS One. 2021;16:e0258443.
    PubMed     Abstract available

  889. JANG H, Ross TM
    Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    PLoS One. 2021;16:e0258453.
    PubMed     Abstract available

  890. ENRIA L, Bangura JS, Kanu HM, Kalokoh JA, et al
    Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra Leone.
    PLoS One. 2021;16:e0258252.
    PubMed     Abstract available

  891. SOWE A, Njie M, Sowe D, Fofana S, et al
    Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    PLoS One. 2021;16:e0258961.
    PubMed     Abstract available

  892. ARNHEIM-DAHLSTROM L, Zarabi N, Hagen K, Bencina G, et al
    Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study.
    PLoS One. 2021;16:e0256642.
    PubMed     Abstract available

  893. GOMES D, Beyerlein A, Katz K, Hoelscher G, et al
    Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany.
    PLoS One. 2021;16:e0259370.
    PubMed     Abstract available

  894. SCHNEIDER JA, Taylor BG, Hotton AL, Lamuda PA, et al
    National variability in Americans' COVID-19 protective behaviors: Implications for vaccine roll-out.
    PLoS One. 2021;16:e0259257.
    PubMed     Abstract available

  895. HYLAND P, Vallieres F, Hartman TK, McKay R, et al
    Detecting and describing stability and change in COVID-19 vaccine receptibility in the United Kingdom and Ireland.
    PLoS One. 2021;16:e0258871.
    PubMed     Abstract available

  896. FANTIN RF, Fraga VG, Lopes CA, de Azevedo IC, et al
    New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates.
    PLoS One. 2021;16:e0258637.
    PubMed     Abstract available

  897. DOHERTY IA, Pilkington W, Brown L, Billings V, et al
    COVID-19 vaccine hesitancy in underserved communities of North Carolina.
    PLoS One. 2021;16:e0248542.
    PubMed     Abstract available

  898. ANDRASIK MP, Broder GB, Wallace SE, Chaturvedi R, et al
    Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    PLoS One. 2021;16:e0258858.
    PubMed     Abstract available

  899. PRENTOE J, Janitzek CM, Velazquez-Moctezuma R, Goksoyr L, et al
    Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
    PLoS One. 2021;16:e0255336.
    PubMed     Abstract available

  900. MUELLER JE, Seanehia J, Yaro S, Trotter CL, et al
    Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns.
    PLoS One. 2021;16:e0253263.
    PubMed     Abstract available

  901. BONAPARTE SC, Adams L, Bakamutumaho B, Barbosa Costa G, et al
    Rabies post-exposure healthcare-seeking behaviors and perceptions: Results from a knowledge, attitudes, and practices survey, Uganda, 2013.
    PLoS One. 2021;16:e0251702.
    PubMed     Abstract available

  902. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
    PLoS One. 2021;16:e0258743.
    PubMed     Abstract available

  903. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Correction: Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0259922.
    PubMed     Abstract available

  904. HEINE F, Wolters E
    Using moral foundations in government communication to reduce vaccine hesitancy.
    PLoS One. 2021;16:e0259435.
    PubMed     Abstract available

  905. GRAY AN, Martin-Blais R, Tobin NH, Wang Y, et al
    Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection.
    PLoS One. 2021;16:e0259703.
    PubMed     Abstract available

    Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2021;16:e0259640.
    PubMed     Abstract available

  907. KISAKA S, Makumbi FE, Majalija S, Kagaha A, et al
    "As long as the patient tells you it was a dog that bit him, why do you need to know more?" A qualitative study of how healthcare workers apply clinical guidelines to treat dog bite injuries in selected hospitals in Uganda.
    PLoS One. 2021;16:e0254650.
    PubMed     Abstract available

  908. MBULAWA ZZA, Somdyala NI, Mabunda SA, Williamson AL, et al
    High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
    PLoS One. 2021;16:e0253074.
    PubMed     Abstract available

  909. STOCKELER AM, Schuster P, Zimmermann M, Hanses F, et al
    Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic.
    PLoS One. 2021;16:e0260213.
    PubMed     Abstract available

  910. KIKUTI M, Sanhueza J, Vilalta C, Paploski IAD, et al
    Porcine reproductive and respiratory syndrome virus 2 (PRRSV-2) genetic diversity and occurrence of wild type and vaccine-like strains in the United States swine industry.
    PLoS One. 2021;16:e0259531.
    PubMed     Abstract available

  911. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed     Abstract available

  912. VENKATESAN MM, Ballou C, Barnoy S, McNeal M, et al
    Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    PLoS One. 2021;16:e0259361.
    PubMed     Abstract available

  913. BAUM U, Poukka E, Palmu AA, Salo H, et al
    Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.
    PLoS One. 2021;16:e0258704.
    PubMed     Abstract available

  914. ISLAM MR, Oraby T, McCombs A, Chowdhury MM, et al
    Evaluation of the United States COVID-19 vaccine allocation strategy.
    PLoS One. 2021;16:e0259700.
    PubMed     Abstract available

  915. BRESLIN G, Dempster M, Berry E, Cavanagh M, et al
    COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour.
    PLoS One. 2021;16:e0259381.
    PubMed     Abstract available

  916. GERRETSEN P, Kim J, Caravaggio F, Quilty L, et al
    Individual determinants of COVID-19 vaccine hesitancy.
    PLoS One. 2021;16:e0258462.
    PubMed     Abstract available

  917. SCHERRER JF, Salas J, Wiemken TL, Hoft DF, et al
    Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts.
    PLoS One. 2021;16:e0257405.
    PubMed     Abstract available

  918. PAPAZOGLOU DD, Baretella O, Feller M, Del Giovane C, et al
    Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    PLoS One. 2021;16:e0260112.
    PubMed     Abstract available

  919. SCHOMMER SK, Harrison N, Linville M, Samuel MS, et al
    Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance.
    PLoS One. 2021;16:e0260052.
    PubMed     Abstract available

  920. ACEVEDO-VILLANUEVA KY, Renu S, Shanmugasundaram R, Akerele GO, et al
    Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds.
    PLoS One. 2021;16:e0259334.
    PubMed     Abstract available

  921. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed     Abstract available

  922. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed     Abstract available

  923. MUHAJARINE N, Adeyinka DA, McCutcheon J, Green KL, et al
    COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    PLoS One. 2021;16:e0259513.
    PubMed     Abstract available

  924. COOKSON D, Jolley D, Dempsey RC, Povey R, et al
    A social norms approach intervention to address misperceptions of anti-vaccine conspiracy beliefs amongst UK parents.
    PLoS One. 2021;16:e0258985.
    PubMed     Abstract available

  925. RAO CY, Robinson T, Huster K, Laws RL, et al
    Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    PLoS One. 2021;16:e0253108.
    PubMed     Abstract available

  926. GOMES LC, Sanson MCG, Brainin P, de Melo MDCV, et al
    Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon.
    PLoS One. 2021;16:e0253752.
    PubMed     Abstract available

  927. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available

  928. VAN EGEREN D, Stoddard M, Novokhodko A, Rogers MS, et al
    Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
    PLoS One. 2021;16:e0258997.
    PubMed     Abstract available

  929. CHACON-DIAZ C, Zabalza-Barangua A, San Roman B, Blasco JM, et al
    Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.
    PLoS One. 2021;16:e0260288.
    PubMed     Abstract available

  930. DEVI YD, Goswami HB, Konwar S, Doley C, et al
    Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
    PLoS One. 2021;16:e0258645.
    PubMed     Abstract available

  931. YAMAMOTO K, Suzuki M, Ujiie M, Kanagawa S, et al
    Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan.
    PLoS One. 2021;16:e0258357.
    PubMed     Abstract available

  932. ZORIGT T, Furuta Y, Simbotwe M, Ochi A, et al
    Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    PLoS One. 2021;16:e0258317.
    PubMed     Abstract available

  933. PHATIHATTAKORN C, Wongsa A, Pongpan K, Anuwuthinawin S, et al
    Seroprevalence of Zika virus in pregnant women from central Thailand.
    PLoS One. 2021;16:e0257205.
    PubMed     Abstract available

  934. LUCHEN CC, Mwaba J, Ng'ombe H, Alabi PIO, et al
    Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.
    PLoS One. 2021;16:e0260552.
    PubMed     Abstract available

  935. MENA G, Casas I, Casan C, Aunon M, et al
    Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    PLoS One. 2021;16:e0260397.
    PubMed     Abstract available

  936. CAPITINE IPU, Macicame IB, Uanela AM, Bhatt NB, et al
    Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    PLoS One. 2021;16:e0260126.
    PubMed     Abstract available

  937. ANJORIN AA, Odetokun IA, Abioye AI, Elnadi H, et al
    Will Africans take COVID-19 vaccination?
    PLoS One. 2021;16:e0260575.
    PubMed     Abstract available

  938. BRAILOVSKAIA J, Schneider S, Margraf J
    To vaccinate or not to vaccinate!? Predictors of willingness to receive Covid-19 vaccination in Europe, the U.S., and China.
    PLoS One. 2021;16:e0260230.
    PubMed     Abstract available

  939. IOANNOU GN, Green P, Locke ER, Berry K, et al
    Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system.
    PLoS One. 2021;16:e0259696.
    PubMed     Abstract available

  940. GUPTA S, Watanabe S, Laurent SM
    Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 pandemic.
    PLoS One. 2021;16:e0260380.
    PubMed     Abstract available

  941. MUSTAPHA M, Lawal BK, Sha'aban A, Jatau AI, et al
    Factors associated with acceptance of COVID-19 vaccine among University health sciences students in Northwest Nigeria.
    PLoS One. 2021;16:e0260672.
    PubMed     Abstract available

  942. ABDOU MS, Kheirallah KA, Aly MO, Ramadan A, et al
    The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries.
    PLoS One. 2021;16:e0260321.
    PubMed     Abstract available

  943. DROPPA-ALMEIDA D, da Silva GA, Gaspar LMDAC, Pereyra BBS, et al
    Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.
    PLoS One. 2021;16:e0256864.
    PubMed     Abstract available

  944. BARRY M, Temsah MH, Alhuzaimi A, Alamro N, et al
    COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.
    PLoS One. 2021;16:e0244415.
    PubMed     Abstract available

  945. POLLOCK BH, Kilpatrick AM, Eisenman DP, Elton KL, et al
    Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020.
    PLoS One. 2021;16:e0258738.
    PubMed     Abstract available

  946. GALLANT AJ, Nicholls LAB, Rasmussen S, Cogan N, et al
    Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
    PLoS One. 2021;16:e0261844.
    PubMed     Abstract available

  947. QAMAR W, Qayum M, Sadiq N
    Assessing the knowledge and skill of vaccination staff at Adult Vaccination Counters for COVID-19 vaccines: Simulated client method.
    PLoS One. 2021;16:e0261286.
    PubMed     Abstract available

  948. FONTENOT HB, Mattheus DB, Lim E, Michel A, et al
    Undergraduate nursing students' COVID-19 vaccine intentions: A national survey.
    PLoS One. 2021;16:e0261669.
    PubMed     Abstract available

  949. MAYAN D, Nguyen K, Keisler B
    National attitudes of medical students towards mandating the COVID-19 vaccine and its association with knowledge of the vaccine.
    PLoS One. 2021;16:e0260898.
    PubMed     Abstract available

  950. YANG C, Yang Y, Li Y
    Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    PLoS One. 2021;16:e0261236.
    PubMed     Abstract available

  951. KING WC, Rubinstein M, Reinhart A, Mejia R, et al
    Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021.
    PLoS One. 2021;16:e0260731.
    PubMed     Abstract available

  952. SUBEDI P, Yadav GK, Paudel B, Regmi A, et al
    Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0260638.
    PubMed     Abstract available

  953. FIRSTOVA VV, Shakhova AS, Riabko AK, Silkina MV, et al
    Characterization of the adaptive immune response of donors receiving live anthrax vaccine.
    PLoS One. 2021;16:e0260202.
    PubMed     Abstract available

  954. ROSETTIE KL, Joffe JN, Sparks GW, Aravkin A, et al
    Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
    PLoS One. 2021;16:e0260808.
    PubMed     Abstract available

  955. MOHAMMED R, Nguse TM, Habte BM, Fentie AM, et al
    COVID-19 vaccine hesitancy among Ethiopian healthcare workers.
    PLoS One. 2021;16:e0261125.
    PubMed     Abstract available

  956. HORIUCHI S, Sakamoto H, Abe SK, Shinohara R, et al
    Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan.
    PLoS One. 2021;16:e0261121.
    PubMed     Abstract available

  957. THOMPSON J, Wattam S
    Estimating the impact of interventions against COVID-19: From lockdown to vaccination.
    PLoS One. 2021;16:e0261330.
    PubMed     Abstract available

  958. Retraction: Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and Long-Term-siRNA Treatment.
    PLoS One. 2021;16:e0261693.

  959. KOESNOE S, Masjkuri N, Adisasmita A, Djauzi S, et al
    A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
    PLoS One. 2021;16:e0250234.
    PubMed     Abstract available

  960. ZENS KD, Baroutsou V, Sinniger P, Lang P, et al
    A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.
    PLoS One. 2021;16:e0247216.
    PubMed     Abstract available

  961. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    PubMed     Abstract available

  962. CASAS-DEZA D, Bernal-Monterde V, Aranda-Alonso AN, Montil-Miguel E, et al
    Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes.
    PLoS One. 2021;16:e0261061.
    PubMed     Abstract available

  963. HOSSAIN MB, Alam MZ, Islam MS, Sultan S, et al
    COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey.
    PLoS One. 2021;16:e0260821.
    PubMed     Abstract available

  964. FERWANA I, Varshney LR
    Social capital dimensions are differentially associated with COVID-19 vaccinations, masks, and physical distancing.
    PLoS One. 2021;16:e0260818.
    PubMed     Abstract available

  965. HARGREAVES HEAP SP, Koop C, Matakos K, Unan A, et al
    Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement.
    PLoS One. 2021;16:e0260216.
    PubMed     Abstract available

  966. KADELKA C, McCombs A
    Effect of homophily and correlation of beliefs on COVID-19 and general infectious disease outbreaks.
    PLoS One. 2021;16:e0260973.
    PubMed     Abstract available

  967. GLAZIK R, Moore H, Kennedy D, Bower H, et al
    A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers' perceptions in high and low- and middle-income countries.
    PLoS One. 2021;16:e0260041.
    PubMed     Abstract available

  968. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available

  969. OYO-ITA AE, Hanlon P, Nwankwo O, Bosch-Capblanch X, et al
    Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    PLoS One. 2021;16:e0257277.
    PubMed     Abstract available

  970. AHSAN A, Dar S, Hassan F, Ghafoor F, et al
    Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.
    PLoS One. 2021;16:e0256816.
    PubMed     Abstract available

  971. MACIUSZEK J, Polak M, Stasiuk K, Dolinski D, et al
    Active pro-vaccine and anti-vaccine groups: Their group identities and attitudes toward science.
    PLoS One. 2021;16:e0261648.
    PubMed     Abstract available

  972. JENSEN EA, Wagoner B, Pfleger A, Herbig L, et al
    Making sense of unfamiliar COVID-19 vaccines: How national origin affects vaccination willingness.
    PLoS One. 2021;16:e0261273.
    PubMed     Abstract available

  973. MIRON VD, Banica L, Sandulescu O, Paraschiv S, et al
    Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    PLoS One. 2021;16:e0258798.
    PubMed     Abstract available

  974. LEE MF, Chiang CH, Lin SJ, Wu CS, et al
    Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
    PLoS One. 2021;16:e0261333.
    PubMed     Abstract available

  975. BERENDAM SJ, Morgan-Asiedu PK, Mangan RJ, Li SH, et al
    Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
    PLoS One. 2021;16:e0256885.
    PubMed     Abstract available

  976. PEREZ CHACON G, Fathima P, Jones M, Barnes R, et al
    Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.
    PLoS One. 2021;16:e0260388.
    PubMed     Abstract available

  977. VEALS AM, Koprowski JL, Bergman DL, VerCauteren KC, et al
    Occurrence of mesocarnivores in montane sky islands: How spatial and temporal overlap informs rabies management in a regional hotspot.
    PLoS One. 2021;16:e0259260.
    PubMed     Abstract available

  978. GUAN TH, Htut HN, Davison CM, Sebastian S, et al
    Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study.
    PLoS One. 2021;16:e0261470.
    PubMed     Abstract available

  979. EZAJ MMA, Haque MS, Syed SB, Khan MSA, et al
    Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination.
    PLoS One. 2021;16:e0252295.
    PubMed     Abstract available

  980. ZEIGLER DF, Gage E, Clegg CH
    Epitope-targeting platform for broadly protective influenza vaccines.
    PLoS One. 2021;16:e0252170.
    PubMed     Abstract available

  981. CHISENGA CC, Bosomprah S, Simuyandi M, Mwila-Kazimbaya K, et al
    Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    PLoS One. 2021;16:e0252222.
    PubMed     Abstract available

  982. GENTILE A, Giglio N, Lucion MF, Martinez AC, et al
    Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
    PLoS One. 2021;16:e0251496.
    PubMed     Abstract available

  983. WOLFF E, Widgren K, Scalia Tomba G, Roth A, et al
    Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    PLoS One. 2021;16:e0251644.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.